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Polydopamine (PDA), a synthetic and organic material, has emerged as a promising material
platform for various applications in energy, environmental, and biomedical fields. PDA, formed
by self-polymerization of dopamine, is rich in catechol and amine groups, which facilitate
covalent conjugation and/or other non-covalent interactions with organic and inorganic
materials. It is highly biocompatible, biodegradable, has broadband light absorption spectrum
and excellent light-to-heat conversion efficiency. Also, it is easy to synthesize and functionalize.
The combination of excellent characteristics of polydopamine-based nanomaterials, make them a
promising adsorbent agent for environmental wastewater treatment and photothermal agent for
biomedical applications.
In the first half of thesis, we utilize the surface chemical functionality of polydopamine
nanoparticles and their affinity to heavy metal ions and organic dyes to realize multifunctional
filtration membranes that remove heavy metal ions and organic dyes from water through
adsorption and catalytic degradation. Polydopamine exhibits high adsorption capacity toward
heavy metal ions and organic dyes. Adsorption-based membrane technologies can be ideal for
continuous flow water purification and have been extensively employed at industrial scale for
xxi

water reclamation. By introducing polydopamine nanoparticles during bacteria-mediated
cellulose growth, we fabricated a composite foam and membrane to study the adsorption
behavior of the nanocomposites in different environmentally relevant pH and concentrations.
The PDA/BNC membrane was used to investigate the removal efficiency of toxic heavy metals
ions such as Pb (II) and Cd (II) and organic pollutants such as rhodamine 6G and methylene
blue. Furthermore, to improve the range of pH in which the composite membrane is effective for
dye removal, we fabricated another novel polydopamine/nanocellulose membrane, which is
decorated with palladium (Pd) nanoparticles to remove organic dyes from contaminated water
through catalytic dye degradation.
In the second part of thesis, we develop polydopamine-based nanomaterials and experimental
setups to be used in biomedical applications such as drug delivery and photothermal stimulation
of cells. Using mesoporous silica-coated PDA nanoparticles as drug carrier and tetradecanol
(TD) as gate keeper, we demonstrated that we could enhance the immune system response
toward Melanoma cancer in mouse model through combination of photothermal and
immunotherapy. Polydopamine core works as a photothermal agent to cause localized release of
gardiquimod and tumor cell death upon NIR laser irradiation, hence, release of tumor associated
antigens. Antigen presenting cells (APCs) including the dendritic cells and macrophages uptake
these antigens and be activated around tumor site in response to these signals. Furthermore, these
activated APCs, present the antigen to CD8+ cytotoxic T cells to actuate anti-tumor immune
response. We have shown that this treatment is effective in reducing the tumor size and
eliminating it in majority of cases. Also, the treatment created a memory effect in immune
system toward melanoma cancer when second cancer event happened in mice that were treated
before.

xxii

Finally, we investigated the possibility of controlling the excitable cells’ activity through
nanoheating. This was made possible by using polydopamine nanoparticles to localize the heat
on cell membrane. We demonstrated that by using polydopamine nanoparticle and
polydopamine/collagen 3D foam, and by applying NIR laser light, we can reversibly modulate
the activity of in vitro cultured neurons and cardiomyocytes. A reduction in firing rate of neurons
and an increase in beating rate of cardiomyocytes with different degree of inhibition and
excitation was observed. Effect of different parameters on the quality of modulation was
investigated.

xxiii

Chapter 1: Background and Motivation
1.1 Polydopamine-Based Nanomaterials
Inspired by mussel’s versatile adhesion capability, including surprisingly strong metal-binding
ability, polydopamine has emerged as a promising material platform for various applications in
energy, environmental, and biomedical fields.1-4 Polydopamine, formed by self-polymerization
of dopamine, is rich in catechol and amine groups, which facilitate covalent conjugation and/or
other non-covalent interactions with organic and inorganic materials.5-11

Polydopamine is

biocompatible and biodegradable, which serves as a great material for reduction of waste in
environmental applications. The applications of PDA coating onto various adsorbents, such as
graphene, graphene oxide, glass beads, magnetic nanoparticles, and most recently, metal-organic
frameworks, was shown to significantly improve their adsorption efficiency toward metal and
organic contaminants.12-16

1.1.1 Polydopamine/Bacterial Nanocellulose Ultrafiltration Membrane for
Adsorption-Based Wastewater Treatment
The growing world’s population and socioeconomic development cause significant increase the
demand for the fresh and clean water. The ever-growing industrialization around the world
brings about more toxic heavy metals and organic contaminants into the natural water resources
than ever.17-19

In response to these impending challenges, various water remediation

technologies based on adsorption, chemical precipitation, membrane filtration, and biological
treatment have been used to remove contaminants from polluted water.20-24

Among them,

adsorption-based methods have been widely used for removing a variety of pollutants from water
because they are simple, low-cost, effective and can be implemented in many parts of the
1

world.20 Several different types of adsorbents, such as carbon-based materials, metal oxides,
silica, and polymers have been shown to remove heavy metal ions and organic pollutants from
contaminated water.16, 20, 25-26 However, these adsorbents are mostly suitable for small-volume
applications and are not compatible with continuous flow water treatment.22 Alternatively,
membrane technologies can be ideal for continuous flow water purification and have been
extensively employed at industrial scale for water reclamation.27-29 Thus, it is of great interest to
develop novel adsorbent membranes that are cost-effective, robust and scalable.

1.1.2 Palladium Nanoparticle-Decorated Mesoporous-Polydopamine/Bacterial
Nanocellulose Ultrafiltration Membrane for Catalytic Removal of Organic
Dyes in Wastewater
Owing to the globally increasing demand for consumer goods, massive amounts of chemical
wastes are produced and released into the environment by industries including textiles, paints,
printing inks, cosmetics, plastics and paper.30 These industrial effluents are highly contaminated
by organic and inorganic compounds with textile wastewater being the most polluting among all
industrial sectors.31 Modern dyes, which are extensively used in many industries, offer superior
color stability because of the high degree of aromaticity and extensive conjugation present in
their chemical structures, which also make them harder to remove from water resources via
traditional water treatment techniques.32-33 Presence of these carcinogenic, mutagenic and
persistent organic contaminants in natural environment, poses a great health risk for humans and
aquatic ecosystems.34-37 This greatly increases the need for the development of highly proficient
and economical dye removal techniques from contaminated water.
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Catalytic degradation of organic dyes by noble and transition metal nanostructures has been
shown to be highly efficient and practical in water remediation in a wide range of environmental
conditions.38-43 To alleviate the aggregation of metal nanoparticles and achieve prolonged
catalytic activity, immobilizing them on various substrates has been proven to be an attractive
approach. A wide range of substrates such as polydopamine (PDA)-based nanoparticle, carbonbased nanoparticles, silica, and metal oxides have been employed for this purpose.24, 44-52 Among
these, PDA has emerged as a promising material platform for the development of catalyticallyactive substrates.1, 48-49, 52 PDA nanoparticles and PDA-based materials were used as substrates
for immobilization of different metals such as silver, gold, palladium and platinum.48-50,

53

However, the use of these stand-alone catalytically active composite particles is highly limited
for practical applications in industrial waste water treatment, due to their colloidal stability,
which requires extra steps to remove them from water. One way to overcome this problem is to
immobilize the metal nanoparticle on membranes for membrane filtration. However, achieving
an ultrafiltration membrane with high water flux and excellent organic dye removal
characteristics is still a challenge.

1.2 Photothermal Applications of Polydopamine-Based
Nanomaterials
Among various nanomaterials that could transform light energy to heat, polydopamine (PDA)
nanomaterials are a particularly promising candidate for photothermal neuronal modulation and
cancer therapy due to their excellent photothermal properties, biocompatibility, biodegradability,
and facile surface functionalization.

54

PDA-based nanomaterials have been widely investigated

as photothermal agents for photothermal cancer therapy.55-57 Furthermore, due to their

3

biocompatibility and superior interaction with cells, PDA-based nanomaterials have been shown
to be promising candidates for neuronal interfacing. 58-60

1.2.1 Mesoporous Silicon Oxide-Coated Polydopamine Nanoparticles as Drug
Carrier and Photothermal Agent for Combined PhotothermalImmunotherapy Cancer Treatment
To achieve concurrent release of antigen and adjuvant by photothermally ablating the tumor cells
for release of tumor associated antigens (TAAs) and simultaneously triggering the release of
adjuvant, there is a need for a photothermally active material and a drug carrier. Recently,
polydopamine has attracted increased attention as a bio-inspired, biocompatible, and
biodegradable photothermal material for various biomedical applications.1,

3, 61-65

Mesoporous

silica, which is employed as shell, exhibits excellent biocompatibility, and complete degradation
into non-toxic components making it an attractive candidate as a drug carrier.66 Mesoporous
silica-coated polydopamine nanoparticles could serve as a great drug delivery vehicle and
photothermal agent for simultaneous photothermal and immunotherapy treatment.

1.2.2 Polydopamine Nanoparticles and Collagen/Polydopamine 3D Foam for
Photothermal Stimulation of Excitable Cells
Among the many methods that aim to modulate the biological processes, a particularly attractive
method is photo-regulation, a process in which light is utilized as an external stimulus.67
Optogenetics, which involves the insertion of light-sensitive ion channels and subsequent
stimulation of these neurons for selective control, has received wide attention.68-69 While
optogenetic techniques are promising and have revolutionized basic research aimed at
understanding the computational and behavioral role of several different neural populations,
there are still several limitations associated with these techniques that remain to be addressed.704

72

To address some of these shortcomings, the use of nanomaterials for non-genetic electrical and

thermal stimulation were explored and tested successfully in recent years.73 Among these,
photothermal methods have shown great promise and versatility in stimulating neuronal cells. 7482

The use of thermal energy as a stimulus to activate neurons could be highly localized to avoid

generic effects on neuronal firing and their behavior. Hence, there is a need for novel
biocompatible nanomaterials to be used to interface them with excitable cells and are
photothermally active to be used for photothermal stimulation of cells.

1.3 Research Goals and Objectives
The goal of this research effort is to synthesize multifunctional polydopamine (PDA)
nanoparticles with well-defined structure and optical properties and to demonstrate their versatile
applications in: (1) wastewater remediation; (2) combined photothermal and immunotherapy
cancer treatment; (3) photothermal activity modulation of neuronal cells. Collectively, by
demonstrating the multifunctional nature of the polydopamine nanomaterials and facile material
synthesis, we have shown several potential applications that could take advantage of properties
of this new class of organic material. We have accomplished several specific technical tasks
noted below to realize these objectives:
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Figure 1.1 Schematic illustration of the overall research goal

1.3.1 Objective 1: Design, fabricate and validate PDA/ bacterial nanocellulose
(BNC)-based functional composite membranes for efficient heavy metal ions
and organic dyes removal from wastewater

Task 1: Investigate the contaminant removal capacity, water flux properties and the
effect of pH and contaminant concentration on the adsorption properties of the PDA/BNC
composite foam and membrane.
Task 2: Investigate the catalytic properties of palladium-decorated mesoporousPDA/BNC membrane, the water flux and membrane’s ability to remove organic dyes from
wastewater.
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1.3.2 Objective 2: Investigate NIR light-triggered photothermal therapy for
improved cancer immunotherapy by using mesoporous silica-coated PDA
nanoparticles

Task 1: Synthesize biocompatible mesoporous silica-coated PDA nanoparticles loaded
with immuno-stimulating agent.
Task 2: Investigate anti-tumor response of photothermally-stimulated mesoporous silicacoated PDA particles loaded with TLR7/8 agonist using mouse melanoma model.

1.3.3 Objective 3: Harness the photothermal properties of PDA nanoparticles
to control the electrical activity of neurons and cardiomyocytes in vitro locally
and focally

Task 1: Devise an experimental setup to photothermally stimulate the primary neuronal
cells and cardiomyocytes cultured on microelectrode arrays in presence of PDA nanoparticles
using NIR light and investigate the nature of change in cells’ activity.
Task 2: Develop a composite foam of collagen-PDA nanoparticle to be used as an add-on
patch for photothermal activity modulation of excitable cells and compare its performance to
PDA nanoparticle.

7

Chapter 2: A Robust and Scalable
Polydopamine/Bacterial Nanocellulose Hybrid
Membrane for Efficient Wastewater Treatment
2.1 Introduction
The growing world’s population and socioeconomic development cause significant increase the
demand for the fresh and clean water. The ever-growing industrialization around the world
brings about more toxic heavy metals and organic contaminants into the natural water resources
than ever.17-19

In response to these impending challenges, various water remediation

technologies based on adsorption, chemical precipitation, membrane filtration, and biological
treatment have been used to remove contaminants from polluted water.20-24

Among them,

adsorption-based methods have been widely used for removing a variety of pollutants from water
because they are simple, low-cost, effective and can be implemented in many parts of the
world.20 Several different types of adsorbents, such as carbon-based materials, metal oxides,
silica, and polymers have been shown to remove heavy metal ions and organic pollutants from
contaminated water.16, 20, 25-26 However, these adsorbents are mostly suitable for small-volume
applications and are not compatible with continuous flow water treatment.22 Alternatively,
membrane technologies can be ideal for continuous flow water purification and have been
extensively employed at industrial scale for water reclamation.27-29 Thus, it is of great interest to
develop novel adsorbent membranes that are cost-effective, robust and scalable.
Inspired by mussel’s versatile adhesion capability, including surprisingly strong metal-binding
ability, polydopamine has emerged as a promising material platform for various applications in
energy, environmental, and biomedical fields.1-4 Polydopamine, formed by self-polymerization
8

of dopamine, is rich in catechol and amine groups, which facilitate covalent conjugation and/or
other non-covalent interactions with organic and inorganic materials.5-11 The applications of
PDA coating onto various adsorbents, such as graphene, graphene oxide, glass beads, magnetic
nanoparticles, and most recently, metal-organic frameworks, was shown to significantly improve
their adsorption efficiency toward metal and organic contaminants.12-16

In membrane

technologies, dopamine coating on commercially available PET/PTFE composite membrane was
used to improve the oil–water separation.83 Due to excellent hydrophilicity of dopamine, it was
used to modify the hydrophobic PVDF membranes to enhance the water flux and its antifouling
performance.84 Because of its photothermal ability, polydopamine coating was also used on
commercial PVDF membranes to achieve localized heating under sunlight for photothermal
membrane distillation.85 Furthermore, it has been shown that PDA particles, as biocompatible
materials could be used independently for a removal of heavy metals and organic contaminants
with an outstanding efficiency.20,

86

However, in those system, PDA particles which are

dispersed in aqueous solution are barely reusable and difficult to collect. Thus, they are less
likely to be suitable for real-world, large-scale applications. For this reason, designing an
innovative and environmentally benign composite materials, immobilized PDA particles in foam
or membrane structures, can be an attractive solution to ensure sustainable water treatment.
Bacterial nanocellulose is a highly attractive material for realizing multifunctional composites
due to its outstanding mechanical strength, diverse chemical functionalization, facile synthesis,
and excellent biocompatibility.87-96 By introducing functional materials into the culture medium
during bacteria-mediated BNC growth, scalable and robust functional composites can be
achieved. Recently, we have demonstrated a novel, highly scalable and cost-effective strategy to
realize BNC-based functional composites.97-99
9

Here, we report the fabrication approach of a low cost, scalable, environmentally friendly, and
reusable composite membrane, which combines the mechanical robustness of BNC and the
adsorption properties of PDA particles. Heavy metal ions such as lead and cadmium, along with
surrogates of organic pollutants such as rhodamine 6G (R6G), methylene blue (MB), and methyl
orange (MO) and combination of these pollutants can be efficiently removed from water by
simple membrane filtration at a low vacuum pressure (0.7 bar). The novel membrane design
introduced here suggest a promising approach for effective water remediation.

2.2 Results and Discussion
The PDA/BNC membrane is fabricated by the addition of PDA particles into Gluconacetobacter
hansenii broth under aerobic and static conditions (Figure 2.1). PDA particles are synthesized by
self-polymerization and air-oxidation of dopamine monomer in water-ethanol-ammonium
mixture at room temperature (Figure 2.2A).10 The size of the PDA particles can be controlled by
varying the amount of ammonium present in the reaction solution, with a higher amount of
ammonium resulting in smaller particles. Optimal PDA particle size is critical for efficient
incorporation of the particles in the BNC fiber network and fabrication of uniform PDA/BNC
hybrid composites. Smaller particles leach out of the BNC network easily under operational
conditions, which compromises the adsorption efficiency of the membrane and causes
unintended contamination of the permeate water. Scanning electron microscopy (SEM) images
showed that the PDA particles are spherical and highly uniform with a diameter around 800 nm
(Figure 2.2B). The Raman spectrum of PDA particles exhibited two broad bands at 1371 cm -1
and 1578 cm-1 corresponding to the characteristic aromatic groups of polydopamine, confirming
the formation of PDA particles (Figure S2.1).100 Fourier transform infrared (FTIR) spectrum of
the PDA particles showed a broad adsorption band at 3341 cm-1, corresponding to the O–H and
10

N–H stretching vibrations of catechol group of the PDA (Figure 2.2C).101 The absorption peak
at 1610 cm-1 can be attributed to the bending ring vibration of N–H and stretching vibration of
aromatic ring, the peak at 1516 cm-1 corresponds to shearing vibration of amide group, and the
peak at 1290 cm-1 corresponds to C-O stretching.102-103
The as-produced PDA/BNC hydrogels were either freeze-dried to form foams for adsorption
experiments in batch reactors or air-dried to form membranes for flow-through filtration tests.
The thickness of the PDA/BNC foam was tuned by simply controlling the duration of the
bacterial growth process. The typical thickness of the PDA/BNC foams used in this study was
~1.1 mm (Figure 2.2D).

Pristine BNC foam, comprised of an entangled network of

nanocellulose fibers with diameters 20–100 nm, exhibited a porous microstructure, while the airdried BNC membrane showed a compact structure of cellulose fibers (Figure S2.2 and S2.3).
We hypothesized that the fibrous network of the BNC matrix can effectively trap 800 nm PDA.
Growth of BNC in the presence of PDA particles resulted in high density and uniform
distribution of PDA particles inside the BNC fiber network, which is important for reliable and
consistent performance of the membrane (Figure 2.2E and F). When the PDA/BNC hydrogels
were air-dried, the cellulose fibers and PDA particles were packed into a thin and dense film
with a thickness of ~50 μm (Figure 2.2G and I). Figure 2H shows that a few layers of BNC
fibers on the surface of the membrane effectively trap PDA particles and prevent them from
leaching out of the membrane.
Thermogravimetric analysis (TGA) was used to measure the PDA loading of the PDA/BNC
composite. TGA was performed in nitrogen using a TA Instruments Q5000 IR
Thermogravimetric Analyzer at a heating rate of 5 ºC min-1. Around 57 % residual weight of
PDA was observed after heating to 800°C under Nitrogen. Pristine BNC film showed an initial
11

mass loss (2–3%) at 100 °C, which is attributed to the loss of residual/adsorbed water, a mass
loss (~70%) at ~280 °C is due to the degradation of cellulose and a mass loss (~25%) at ~390 °C
is due to the decomposition of cellulose residual, which generates CO2 and H2O.104 In the case
of PDA/BNC, the initial mass loss (~8 %) at ~100 °C is due to the loss of residual water. The
second mass loss (~30%) at 280 °C is due to the degradation of cellulose and the degradation of
PDA particles. After heating to 800 °C, 33% of initial weight of PDA/BNC membrane remained.
Based on TGA results, the mass loading of PDA in PDA/BNC is calculated to be ~ 44 wt%
(Figure S2.4).

To study the adsorption behaviors of PDA/BNC composites, we performed batch adsorption
tests using heavy metal ions and organic dyes (Figure 2.3A). Pb (II) was selected as a model
heavy metal ion. In this experiment, the initial pollutant concentration and pH were adjusted and
then PDA/BNC or BNC (control) foam was weighed and placed in the known volume of the
pollutant solution. The adsorbent was left under gentle shaking until it reached equilibrium
condition. Subsequently, pollutant concentrations in the solution were measured to calculate the
adsorption capacity. The solution pH affects the surface potential (zeta-potential) of the PDA
particles and BNC, thereby changing their adsorption behaviors. In our experimental systems,
the isoelectric point (pHiep) of BNC and PDA particles was found to be 2.4 and 3.3, respectively
(Figure 2.3B), and the zeta-potential of BNC and PDA particles decreased with an increase in the
pH of the solution.

Specifically, the adsorption capacity of BNC and PDA/BNC foams for Pb (II) increased with the
pH increased (Figure 2.3C). At pH values below pHiep, the positively charged surface repels the
positively charged Pb (II) ions, and hence, lower adsorption capacities were observed at pH < 3
12

(Figure 2.3C). At pH values above pHiep, the surface of the adsorbent is negatively charged
because of the ionization of oxygen-bearing functional groups on the surface.

Negatively

charged surface provides favorable interactions for adsorption of Pb (II) ions. The adsorption
capacity was found to significantly increase for both BNC and PDA/BNC foams at pH values
above their isoelectric point and below pH 6 (Figure 2.3C). At pH > 6, hydrolysis of the Pb (II)
ions possibly transforms them into metal hydroxides and result in precipitation.105

The

adsorption capacities of BNC and PDA/BNC foams were acquired at pH 6. Upon increasing the
Pb (II) ion concentrations, the adsorption capacity for both BNC and PDA/BNC foams increased
until they reach a saturation point (Figure 2.3D). Incorporation of PDA particles in the BNC
matrix significantly increased the Pb (II) adsorption capacity of the composite from 5 mg g-1 for
BNC to 16.8 mg g-1 for PDA/BNC. This could be mainly due to the presence of active
catecholamine functional groups on the PDA surface and their strong affinity to heavy metals. 20
The XPS spectra of the PDA/BNC before and after the adsorption were used to confirm the
adsorption of the Pb (II) ions and their interactions with the adsorbents (Figure S2.5). The C 1s,
N 1s, and O 2p peaks at ~285.2 eV, ~398.4 eV and ~531.7 eV, respectively, correspond to the
elemental composition of PDA/BNC before the adsorption (N 1s spectrum comes from PDA
only). The presence of Pb 4f binding energy peak (at 137.4 eV and 142.3 eV) after exposure to
Pb salt solution confirmed the successful Pb (II) adsorption onto the PDA/BNC. The Pb 4f
spectrum for lead (II) nitrate exhibits two peaks at 138.1 eV and 143 eV (Figure S2.5B). Upon
its adsorption onto PDA/BNC, the two peaks shifted to lower energy levels by 0.7 eV,
suggesting the reaction of Pb (II) and phenolic groups on the surface of the PDA (Figure
S2.5C).16 Furthermore, we compared the PDA particle’s ability to remove Pb (II) with that of
activated carbon, which is one of the most commonly used adsorbents (Figure S2.6). The PDA
13

particles showed 77% higher adsorption capacity compared to activated carbon for lead ions
when normalized by the weight of the adsorbents. Although the specific surface area of PDA
particles (1446 m2 g-1) is lower than that of the activated carbon (1594 m2 g-1), interestingly,
PDA particles exhibited superior Pb (II) adsorption capacity compared to activated carbon.
These observations indicate the better affinity of the lead ions to the PDA particles over activated
carbon, possibly due to the presence of catecholamine groups on the PDA surface.20

To examine the organic pollutant removal efficiency of the PDA/BNC foam, R6G was employed
as a model positively charged organic contaminant. Over a pH range of 2 to 8, the adsorption
capacity of both BNC and PDA/BNC increased with an increase of the pH (Figure 2.4A). With
an increase in pH of the solution, the adsorbent surface is more negatively charged and results in
higher adsorption of the positively charged dye (R6G).

However, above pH 7 due to

deprotonation of amine groups of the dye, the interaction weakens, and the adsorption capacity
decreases. We tested the adsorption capacity of BNC and PDA/BNC foams at different initial
concentrations of R6G at pH 7 (Figure 2.4B). The adsorption capacity for both foams increased
with an increase in the concentration of the dye until it reached a saturation point. PDA/BNC
showed improved performance with a maximum adsorption capacity of 8.7 mg g-1 compared to
BNC (1.8 mg g-1).

The superior performance by PDA/BNC may be related to the π-π

interactions between aromatic moieties of PDA and R6G along with the hydrogen-bonding
interactions between catecholamine groups on PDA and amine groups of the R6G.106

To analyze the nature of adsorption of heavy metal ions and organic pollutants, the experimental
data were fitted using the following Langmuir adsorption isotherm (Equation 2.1).
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(2.1)

Where qe is the adsorption capacity (mg g-1) corresponding to equilibrium concentration, Ce (mg
L-1). Qmax is the maximum uptake (mg g-1), and KL is the binding constant (L g-1). The fitting
parameters corresponding to these curves are provided in Table S1 in supporting information.
For both Pb (II) and R6G, the Langmuir model describes the adsorption behavior quite well
(R2>0.97), suggesting that the adsorption of lead ions and R6G occurred on the functional groups
on the surface of the adsorbents in a monolayer manner.16
Considering that the PDA/BNC foam exhibited high efficiency in adsorbing heavy metal ions
and organic dye, we set out to investigate the performance of PDA/BNC as a filtration membrane
for continuous and rapid removal of contaminants in feed water (Figure 2.5A). Membranes
obtained through air-drying of the PDA/BNC hydrogel were cut into circular pieces with a
diameter of 3 cm. The membranes were fixed on a vacuum filtration setup and a vacuum
pressure of 0.7 bar was applied. Typical metal ion pollutants (i.e., Pb (II) and Cd (II)) along with
organic dyes (i.e., R6G, MB, and MO) were used in membrane filtration tests.

The

concentration of the pollutants in the feed water was adjusted to match that of polluted water
sources and the pH of water was adjusted to match the optimum performance of the membrane
for each pollutant (as determined from the batch adsorption measurements, see Figure S2.7 for
optimum pH value for Cd (II) and MB). The experiments with pristine BNC membranes did not
generate any flow at 0.7 bar (vacuum) due to the small pore size of the BNC membrane.
Therefore, no vacuum filtration data was obtained for BNC membrane. Impregnating the BNC
matrix with PDA particles, provided additional nanochannels for water to pass through the
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membrane. This in turn, enabled filtration with water flux reaching 57 L m-2 hr-1 at 0.7 bar (10
psi) vacuum pressure (water inlet pressure at the kitchen faucet: 25–75 psi). To measure the
upper and lower limits of the pore sizes of the BNC membrane, we performed diffusion test with
DL-Tryptophan, R6G, and lysozyme. Within the observation time (5 hours), all of them diffused
through the BNC membrane showing that pore size for BNC membrane is larger than ~ 1 nm
(Figure S2.8A). To determine the upper limit of the pore size for BNC membrane, diffusion test
was performed by using gold nanoparticles (AuNPs) with a diameter of 5 nm. After 24 hours, no
AuNP was found on the permeate side, indicating that the pore size for the BNC membrane is
less than 5 nm (Figure S2.8A). For PDA/BNC membrane, vacuum filtration at 0.7 bar pressure
was used to filter the colloidal solution of 5 nm and 10 nm AuNPs (Figure S2.8B). As evident
from the extinction spectrum, 5 nm AuNPs penetrate through the membrane, but 10 nm AuNPs
are blocked from passing through the membrane even after 4 hours of filtration. These results
indicate the upper limit of the pore size of PDA/BNC to be 10 nm, which is higher than that
noted for BNC membranes.

The first heavy metal pollutant tested was Pb (II) with an initial concentration of 58 ppm and pH
adjusted to 6. The permeate water concentration was measured repeatedly and the experiment
was carried out until a detectable amount of Pb (II) was observed on the permeate side (Figure
2.5B). The Pb (II) concentration in the feed and permeate was determined using inductively
coupled plasma optical emission spectrometry (ICP-OES) with a detection limit of 50 ppb. A
total amount of 225 ml of 58 ppm Pb (II) aqueous solution was filtered through the membrane
with undetectable levels of Pb (II) on the permeate side. The filtration test was carried out for
Cd (II) solution with initial concentration of 50 ppm and a total amount of 125 ml was filtered to
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a concentration below the limit of the detection of the ICP-OES (Figure 2.5C). The PDA/BNC
membrane showed superior performance in removing Pb (II) solution compared to Cd (II).
Furthermore, after each filtration test of heavy metal ions, the PDA/BNC membranes were
regenerated to recover their heavy metal ions removal efficiency (inset of Figure 2.5B). Aqueous
sodium citrate (0.1 M) solution was employed for regenerating the membrane. Note that sodium
citrate is a mild regeneration agent compared to the typically employed strong acids,
necessitating multiple wash steps for complete regeneration. The use of such mild regeneration
agent preserves the membrane integrity and extends the lifetime of the membrane for repeated
use. The regenerated membranes exhibited excellent contaminant removal efficiency even after
10 cycles of filtration (about 90% of the initial performance retained).
For organic pollutants, the initial concentration for each pollutant was adjusted to mimic
industrial wastewater source.22 For R6G and MB as model positively charged dyes, the initial
pH was adjusted to 7 and 10, respectively (Figure S2.9A for chemical structure of the dyes). In
case of R6G, 105 ml of dye solution was filtered from 51 ppm to below 0.05 ppm (Figure 2.6A).
For MB, 120 ml solution with initial concentration of 47 ppm was filtered to a concentration
below 0.05 ppm (Figure 2.6B). The last organic pollutant tested was MO as model negatively
charged dye (Figure S2.10). At pH 7, it was observed that no MO dye was removed from the
water because of the electrostatic repulsion between negatively charged dye and negatively
charged membrane. Then, the initial pH value for MO solution was adjusted to ~2.4 for
filtration purpose. At this pH, only 25 ml of MO solution with an initial concentration of 55 ppm
was filtered with high efficiency (Figure S2.10A). The filtration performance for MO was
significantly lower than R6G and MB, suggesting that PDA/BNC membrane, and generally
PDA-based adsorbents, are not suitable choices for removing negatively charged pollutants. To
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demonstrate the reusability of the membranes, after R6G filtration, the membrane was
regenerated using ethanol. The PDA/BNC membrane retained more than 90% of its R6G
removal capacity after 10 cycles of filtration and regeneration (inset of Figure 2.6A).
To investigate the versatility of the PDA/BNC membrane when exposed to feed water with
multiple contaminants, an inorganic–organic mixed solution of Pb (II), Cd (II), R6G, and MB
was prepared and filtered through the PDA/BNC membrane. In this competitive adsorption test,
the PDA/BNC membrane removed 5.3 g of Pb (II) from water per square meter of the membrane
area (Figure 2.6C). The lowest performance was observed for Cd (II) with 2.1 g of ions removed
per square meter of the membrane area, which might be because of lower binding affinity of Cd
(II) to carboxylic and phenolic groups compared to lead ions.107

Organic dyes were also

effectively removed from the mixture with total removal capacity of 4.3 g m-2 and 3.8 g m-2 for
R6G and MB, respectively. The strongly green colored cocktail solution became completely
colorless after the vacuum filtration demonstrating an efficient filtration process with only a
single run (Figure 2.6D and Figure S2.9B). To put this into perspective, 5300 L of water
contaminated with lead ions at a concentration of 1 ppm (much higher than EPA recommended
safe level of 15 ppb) could be filtered to a safe concentration by using PDA/BNC membrane of
1×1 m2.
The mechanical stability of the PDA/BNC membrane was investigated by subjecting it to
extensive sonication (Cole-Parmer ultrasonic cleaner #8890, 5 hours) and agitation (speed 3 on
standard analog shaker, 30 days).

The membrane did not exhibit noticeable signs of

disintegration or loss of PDA particles from the BNC matrix after the shaking and sonication
process (Figure 2.7A). The in situ fabrication method adopted here allowed for up to 44 wt%
loading of the PDA particles inside the BNC network (Figure 2.7B, detailed thermogravimetric
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analysis (TGA) is provided in the supporting information). TGA of the PDA/BNC membrane
after sonication (5 hours), demonstrated no discernible change in the weight fraction of the PDA
particles inside the PDA/BNC composite, suggesting the high mechanical integrity of the
membrane (Figure 2.7B). The absorption spectrum of the bath solution in which PDA/BNC
membrane was submerged during 5 hours of sonication did not exhibit light absorption
corresponding to the PDA particles, further confirming the high mechanical stability of the
PDA/BNC membranes and negligible amount of particle leaching (Figure 2.7C). SEM images
of the membrane before and after the sonication exhibited no perceivable change in the structure
of the PDA/BNC membrane (Figure 2.7D). Overall, the stability tests proved the excellent
mechanical stability of the membranes, which is critical for their real-world applications. The
performance of the membrane before and after the stability test was investigated using 100 ppm
R6G as feed solution at pH 7. The PDA/BNC membrane retained 81% of its initial efficiency in
removing the pollutants. We also noted a ~10% increase in water flux, possibly due to small
structural changes that could not be perceived with SEM imaging. While there is a noticeable
change in the membrane performance, it is important to note that the stability test performed here
is quite harsh and represents an accelerated form of real-world application of the membrane.

2.3 Conclusion
To summarize, we introduced a novel PDA/BNC composite adsorption membrane which has
potential to treat wastewater containing multiple inorganic and organic pollutants.

The

PDA/BNC membrane is fabricated by incorporating high density PDA particles inside BNC
matrix during its growth. This fabrication technique is highly versatile and can be easily adapted
to incorporate other adsorbents. All the materials used in the membrane fabrication process are
biocompatible and biodegradable. The unique fabrication process resulted in a highly uniform
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distribution of PDA particles within the BNC matrix. The highly flexible thin film PDA/BNC
membrane exhibited excellent aqueous stability and fast water transport (57 L m-2 hr-1 under 10
psi).

The PDA/BNC membrane showed effective contaminant removal from feed water

containing heavy metal ions and positively charged organic dyes at high concentrations (40–60
ppm). The membrane was found to be equally effective in removing either a single pollutant or
pollutant cocktail (the concentrations of contaminants in permeate side decreased to less than
0.05 ppm). The PDA/BNC membrane can also be regenerated easily and reused for several times
without a significant degradation in its adsorption capacity. The facile, inexpensive, and scalable
synthesis, excellent mechanical robustness and highly efficient removal of heavy metals and
organic dyes under complex conditions and the ability to modify the PDA surface for variety of
water treatment systems, collectively make PDA/BNC membrane demonstrated here a promising
and powerful candidate for wastewater treatment.

2.4 Experimental Section
Sample Preparation: All chemicals were purchased from Millipore Sigma, St. Louis, USA and
used without further modification. Polydopamine particles were synthesized by using a method
explained elsewhere.10 In a typical synthesis procedure of polydopamine particles, 252 ml of
deionized (DI) water (resistivity > 18.2 MΩ·cm) was mixed with 112 ml of ethanol in a 1000 ml
glass container. Subsequently, 1.12 ml of aqueous solution of ammonia (28–30% NH4OH) was
introduced into the above water/ethanol mixture. After stirring for 30 min, the aqueous solution
of dopamine hydrochloride (1.4 g in 28 ml) was added to the above solution. The reaction was
left under gentle magnetic stirring for 24 hours with no cap on the glass container. The PDA
particles were collected by centrifugation (7000 rpm, 10 min) and washed with DI water three
times and dispersed in water (320 ml).
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A fabrication technique that we introduced in our previous work was used with some
modifications to synthesize the PDA/BNC composite.108 Bacterium Gluconacetobacter hansenii
(ATCC®53582) was cultured in test tubes containing 16 ml of #1765 medium at 30 °C under
shaking at 250 rpm. The #1765 medium is composed of 2 % (w/v) glucose, 0.5 % (w/v) yeast
extract, 0.5 % (w/v) peptone, 0.27 % (w/v) disodium phosphate, and 0.5 % (w/v) citric acid.
PDA particle solution (160 ml) was centrifuged, and the pellets were dispersed in the mixture of
bacterial culture solution and the bacterial growth solution (1.5 ml and 13.5 ml, respectively).
This mixture was then transferred to a petri dish (6 cm diameter). After 1-2 hours that the PDA
particles precipitated at the bottom of the petri dish, the excess culture solution was removed.
Two days later, a thin uniform layer of PDA-filled BNC was formed. The PDA/BNC hydrogel
was collected and washed in boiling water for 2 hours, then dialyzed in DI water for one day.
Then, the PDA/BNC hydrogels were either freeze-dried for batch adsorption tests or air-dried for
filtration tests. The PDA/BNC fabrication process relies on PDA particles to completely settle
down during the first 1-2 hours of the growth process. Hence, particles with the size around 800
nm, that settle down in less than 1 hour were synthesized to incorporate into BNC matrix.
Materials Characterization: Scanning electron microscope (SEM) images were obtained by
using a JEOL JSM-7001 LVF Field Emission SEM.

Zeta potential measurements were

performed using Malvern Zetasizer (Nano ZS). Shimadzu UV-1800 spectrophotometer was
employed for light absorption measurements. Raman spectra were obtained using a Renishaw
inVia confocal Raman spectrometer mounted on a Leica microscope with 20× objective and 785
nm wavelength diode laser as an illumination source. Versa Probe II X-Ray Photoelectron
Spectrometer (XPS) was used to acquire XPS spectra.

Fourier-transform infrared (FTIR)

spectrum was obtained on Nicolet 470 (Thermo Scientific). The specific surface area was
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estimated from nitrogen adsorption/desorption isotherms by using Brunauer–Emmett–Teller
(BET) method and a surface area analyzer (Autosorb‐1C).
Batch Adsorption Experiments: To evaluate the adsorption behavior of PDA/BNC, batch
adsorption tests were conducted at room temperature. To investigate the effect of pH, a small
piece of PDA/BNC foam was placed in 5 ml solution of each pollutant and left shaking until it
reached equilibrium. For heavy metals, pH values from 2 to 6 and for organic pollutants pH
values from 2 to 10 were tested. The solution pH was controlled by adding HCl and NaOH to
original solutions. At an optimum pH value for each pollutant, PDA/BNC foam was immersed
into solutions with different initial concentrations and left shaking to reach equilibrium. For
R6G, methyl orange and methylene blue, UV-vis absorption spectroscopy is used to measure the
concentrations before and after the adsorption. Then, an Inductively coupled plasma-optical
emission spectroscope (ICP-OES PE Optima 7300DV) was utilized to evaluate the heavy metal
concentrations. To compare the PDA with a commonly used adsorbate such as activated carbon,
similar weight of each absorbent was added into 15 ml of 200 ppm Pb (II) solution in a glass
vial. Glass vials were subjected to mild shaking for a day, and Pb (II) concentrations before and
after the test were measured. The removal capacity (q) for each pollutant was calculated by the
equation below.
(2.2)

where, C and C0 are the initial and final concentration of the pollutant (in ppm), respectively, V is
the volume of the contaminated water used (in L) and m is the weight of adsorbents (in gram).
Each experiment was replicated three times and error bar for each data point shows the standard
deviation of these three runs.
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Membrane Filtration Experiments: Filtration experiments were carried out by using a vacuum
filtration setup. A concentration of each pollutant was prepared, and the pH was adjusted to the
corresponding optimal pH value for each pollutant. At typical pressure of 0.7 bar, vacuum
filtration was performed in wet state, until the concentration of the filtered water for each
pollutant exceeded the limit of detection of the corresponding measuring system. All the
membranes used in vacuum filtration had 3 cm diameter. Then, membrane was regenerated
using ethanol for organic dyes and 0.1 M sodium citrate solution for heavy metals. After each
filtration test, the membrane was regenerated by placing it in the washing solution and shaking it
for 2 hours for each washing cycle. The washing solution was measured each time to estimate the
amount of regenerated pollutants. Washing cycles were continued until no pollutant was
observed in the washing solution.

2.5 Supporting Information
Supporting Information for chapter 2 is provided in appendix 1.
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2.6 Figures

A

B

Figure 2. 1 (A) Photographs of PDA/BNC membrane during different fabrication steps. (B)
Schematic representation of the fabrication process of PDA/BNC membrane.
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Figure 2. 2 (A) Photograph of the PDA particle solution. (B) SEM images of as-synthesized PDA
particles (inset shows the higher magnification SEM image). (C) FTIR absorption spectrum of
the PDA particles. Optical images (D), SEM images of the (E) surface and (F) cross-section of
the freeze-dried PDA/BNC composite. Optical images (G), SEM images of the (H) surface and
(I) cross-section of the air-dried PDA/BNC membrane.
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A

B

C

D

Figure 2. 3 (A) Schematic illustration of the batch adsorption test. (B) Zeta potentials of the
PDA particles and BNC dispersion at different pH values. (C) Adsorption capacities of
PDA/BNC and pristine BNC foams for Pb (II) at different pH values (experiments carried out at
room temperature and the initial concentration of the contaminants was 200 ppm (D) Pb (II)
adsorption isotherms of PDA/BNC and BNC foams and curve fitting by Langmuir (dash line)
model (The initial pH value was adjusted to 6). (Number of replicates = 3, Error bars for BNC
samples are small compared to the graph scale.)

26

A

B

Figure 2. 4 (A) R6G adsorption capacities of PDA/BNC and pristine BNC foams at different pH
values (experiments carried out at room temperature and the initial concentration of the
contaminants was 200 ppm). (B) R6G adsorption isotherms of PDA/BNC and BNC foams and
curve fitting by Langmuir (dash line) model (initial pH value was adjusted to 7). (Number of
replicates = 3, Error bars for BNC samples are small compared to the graph scale.)
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A

B

C

Figure 2. 5 (A) Schematic illustration of membrane filtration experiment. Permeate water
concentrations after filtration of (B) Pb (II) with a feed concentration of 58 ppm (inset shows
PDA/BNC membrane performance after 10 cycles of Pb (II) filtration-regeneration); (C) Cd (II)
with a feed concentration of 50 ppm.
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A

B

C

D

Figure 2. 6 Permeate water concentrations after filtration of (A) R6G with a feed concentration
of 51 ppm (inset shows 10 cycles of filtration-regeneration of R6G) and (B) MB with a feed
concentration of 47 ppm. (C) Single filtration tests of cocktail solution containing Pb (II) and Cd
(II) ions as well as R6G and MB organic dyes (The bars on the left (red) show original
concentration, and on the right (black) show total uptake). (D) Optical images of mixture
solution before and after the cocktail filtration test.
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D

Figure 2. 7 (A) Optical images of the PDA/BNC composite before and after extensive sonication
and mechanical agitation. (B) Weight loss profiles of PDA/BNC composite before and after
sonication (5 hrs) obtained by TGA. (C) UV-vis spectra of the PDA particles (13.5 mg L-1) and
bath solution used for sonicating PDA/BNC membrane for 5 hrs (The inset is the optical image
of the PDA particle solution (left) and bath solution used for sonication (right)). (D) SEM
images of the PDA/BNC membrane before and after sonication (5 hrs).
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Chapter 3: Palladium Nanoparticle-Decorated
Mesoporous Polydopamine/Bacterial Nanocellulose as
a Catalytically Active Universal Dye Removal
Ultrafiltration Membrane
3.1 Introduction
Owing to the globally increasing demand for consumer goods, massive amounts of chemical
wastes are produced and released into the environment by industries including textiles, paints,
printing inks, cosmetics, plastics and paper.30 These industrial effluents are highly contaminated
by organic and inorganic compounds with textile wastewater being the most polluting among all
industrial sectors.31 Modern dyes, which are extensively used in many industries, offer superior
color stability because of the high degree of aromaticity and extensive conjugation present in
their chemical structures, which also make them harder to remove from water resources via
traditional water treatment techniques.32-33 Presence of these carcinogenic, mutagenic and
persistent organic contaminants in natural environment, poses a great health risk for humans and
aquatic ecosystems.34-37 This greatly increases the need for the development of highly proficient
and economical dye removal techniques from contaminated water.

To treat water resources contaminated with organic pollutants, several different technologies
such as membrane filtration, catalytic degradation, photocatalytic oxidation and adsorption have
been employed.109-119 Among them, adsorption is one of the most commonly-used method for
removing a variety of organic pollutants from water because of its simplicity and low cost.120
However, adsorption alone cannot remove all the different dyes and not all adsorption-based
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techniques are able to operate in a broad range of environmentally-relevant pH conditions.121-122
Alternatively, catalytic degradation of organic dyes by noble and transition metal nanostructures
has been shown to be highly efficient and practical in water remediation in a wide range of
environmental conditions.38-43 Among transition metals, palladium nanoparticles (PdNPs) have
attracted special attention for dye degradation owing to its excellent catalytic properties and low
environmental impacts.123-125 Through catalytic degradation, the toxic organic pollutants with
intrinsic poor biodegradability can be converted to degradable molecules through the electron
transfer between catalysts and pollutants.49 However, metal nanostructures when used as standalone (colloidal state) catalysts, tend to aggregate in solution and cause secondary
contaminations, which makes the recovery of these nanostructures challenging.126-128

To alleviate the aggregation of metal nanoparticles and achieve prolonged catalytic activity,
immobilizing them on various substrates has been proven to be a feasible approach. A wide
range of substrates such as polydopamine (PDA)-based nanoparticle, carbon-based
nanoparticles, silica, and metal oxides have been employed for this purpose.24, 44-52 Among these,
PDA, mussel-inspired synthetic polymer, has emerged as a promising material platform for the
development of catalytically-active substrates.1,

48-49, 52

PDA nanoparticles and PDA-based

materials were used as substrates for immobilization of different metals such as silver, gold,
palladium and platinum.48-50,

53

However, the use of these stand-alone catalytically active

composite particles is highly limited for practical applications in industrial waste water
treatment, due to their colloidal stability, which requires extra steps to remove them from water.

Membrane technologies are being widely used by different industries due to their stability and
ability to be used in continuous flow and high throughput dye removal setups.27, 29, 129-130 In our
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previous work, we demonstrated the use of solid PDA nanoparticle incorporated into
nanocellulose matrix (PDA/BNC) as adsorption-based filtration membrane for removing organic
dyes and heavy metals.130 However, PDA/BNC membrane effectiveness in removing organic
dyes was limited to cationic dyes and to pH values above 4-5. Incorporating catalytically active
composite particles into membrane matrix can provide a highly efficient dye removal membrane
for real-world applications. Several different types of membrane such as GO/BNC, PVDF, PET
and cellulose acetate have been employed as efficient dye degradation membrane for methyl
orange (MO), 4-nitrophenol (4NP), methylene blue (MB), Congo Red and 2,6-dinitrophenol.44,
131-134

However, achieving an ultrafiltration membrane with high water flux and excellent

organic dye removal characteristics is still a challenge.

Herein, we report a facile, scalable and highly efficient catalytically active ultrafiltration
membrane based on bacterial nanocellulose (BNC) loaded with mesoporous PDA (mPDA)
nanoparticles and palladium nanostructures. Mesoporous PDA nanoparticles are embedded into
the BNC matrix during the growth process of BNC to generate mPDA-BNC membrane followed
by in situ growth of Pd nanoparticles on mPDA nanoparticles and BNC fibers. Although
Palladium is expensive, it is a popular catalyst for dye degradation due to its high efficiency and
inert nature. Incorporation of bowl-like mPDA particles inside BNC matrix increases the pore
size of the composite and provides high surface area for Pd nucleation and growth, which results
in higher Pd loading compared to pristine BNC membrane. Moreover, due to the higher porosity
of the membrane the water flux for the membrane is significantly higher compared to the
existing commercial ultrafiltration membranes with the same range of pore size.135 The PdmPDA-BNC membrane exhibited high degradation efficiency in removing anionic (MO), neutral
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(4NP) and cationic (MB) dyes over a wide range of environmentally relevant pH conditions (39), making it an outstanding candidate for real-world applications in wastewater treatment.

3.2 Results and Discussion
3.2.1 Preparation of Pd-mPDA-BNC Membrane
Mesoporous polydopamine-bacterial nanocellulose (mPDA-BNC) membrane was fabricated by
the addition of mPDA particles into Gluconacetobacter hansenii broth under aerobic and static
conditions (Figure 3.1). Mesoporous bowl-like polydopamine nanoparticles were synthesized
based on formation of block copolymer F127, PDA, and 1,3,5 trimethylbenzene (TMB) micelles
at water/TMB emulsion interfaces followed by island nucleation and anisotropic growth on the
surface of emulsion droplets.136 Using this technique, porous polydopamine nanoparticles with
the diameter of ~200 nm were formed with mesoscale channels (~11 nm diameter, ~21 nm
center-to-center distance) aligned radially from the center to the surface (Figure 3.2A).

To synthesize palladium-decorated mPDA-BNC, we have employed two different approaches:
(i) direct growth of Pd nanoparticles in the mPDA nanoparticles followed by their dispersion in
bacteria growth solution to create membrane; and (ii) dispersion of mPDA particles into the
bacteria growth solution to fabricate a composite membrane, followed by the formation of Pd
nanostructures on nanocellulose fibers and mPDA nanoparticles. For the first approach, mPDA
nanoparticles were dispersed in palladium chloride (PdCl2) solution, which resulted in loading of
the mPDA nanoparticles with Pd2+ ions formation of coordination compounds.137-138
Subsequently, the mPDA nanoparticles were transferred to sodium borohydride (NaBH4)
solution to reduce the precursor (Pd (II) ions) to metallic palladium. The Pd nanoparticles were
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primarily formed inside the pores of mPDA particles as shown in TEM image (Figure 3.2B).
This is probably due to the trapping of Pd (II) ions inside the pores through electrostatic
interactions between PDA and heavy metal ions, which prevents their during washing steps. 2
High-resolution transmission electron microscopy (HRTEM) of Pd decorated mPDA
nanoparticles (Pd-mPDA) revealed lattice fringes with a lattice spacing of 0.23 nm,
corresponding to (111) planes of Pd (Figure 3.2C). To create thin-film membrane,
Gluconacetobacter hansenii bacterium was utilized to produce a non-woven network of cellulose
nanofibers called bacterial nanocellulose. In the past, we have shown that various 2D
nanomaterials such as graphene oxide and MoS2 nanosheets and spherical nanoparticles such as
SnO2 and PDA nanoparticles can be trapped inside the nanocellulose network by adding these
nanomaterials into the bacterial culture medium, resulting in a composite multi-functional
structure.130, 139-141 However, addition of the palladium-decorated mPDA particles to the growth
solution inhibited the formation of cellulose network due to the antibacterial properties of the Pd
nanostructures.142 Hence, we employed the second approach for the fabrication of the membrane.
Pd-mPDA particles were used to compare dye removal efficiency of pristine mPDA and PdmPDA nanoparticles. With no additives in bacterial culture medium, under typical growth
conditions, a 1 mm thick cellulose hydrogel is formed after 2 weeks. Air-dried pristine BNC
membrane is comprised of a dense network of cellulose nanofibers with a diameter of ~20-100
nm (Figure 3.2D). The cross-section SEM images of the pristine BNC membrane showed a
uniformly layered structure with overall thickness of 7 μm (Figure S3.1A, supporting
information). Addition of mPDA nanoparticles into the bacterial broth solution resulted in
trapping of the mPDA nanoparticle within the nanocellulose fiber network. The resulting airdried membrane exhibited highly porous structure compared to the pristine membrane as the
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tight packing of the nanofibers is hindered by the presence of the PDA nanoparticles with
hundreds of nanometers in size, which provide physical barriers for fiber-fiber interaction and
collapse (Figure 3.2E). The air-drying process removes water from the expanded cellulose fiber
network, thus causing the collapse of the 3D open porous network into compact film. The
cellulose fibers form extensive inter-fiber hydrogen bonds, which results in small pore size of the
membrane and significant loss in swellability upon rehydration.143 The Pd NPs were in situ
grown in the mPDA-BNC composite by exposing the mPDA-BNC membrane to Pd (II)
precursor (palladium chloride) solution and subsequent reduction using a strong reducing agent,
NaBH4. Scanning electron microscopy images revealed that palladium nanostructures were
formed on mPDA particles and BNC fibers throughout the membrane (Figure 3.2F).

The Pd growth on the mPDA-BNC membrane is notably different from that on mPDA particles.
The size of Pd nanostructures and areal coverage of the Pd nanostructures was significantly
higher compared to that observed in free mPDA nanoparticles in solution. This difference in the
structure and coverage of Pd nanostructures possibly stems from the more efficient trapping of
the Pd precursor within the composite membrane compared to the nanopores of the free mPDA
nanostructures. The cross-section SEM images of the Pd-decorated mPDA-BNC (Pd-mPDABNC) showed uniform Pd formation with increased membrane thickness of 17 μm (Figure
S3.1B, supporting information). This increase in the membrane thickness comes from
combination effect of mPDA particle trapping in BNC matrix and growth of Pd nanostructures in
situ. For comparison, the same procedure was used to create Pd nanostructures on the pristine
BNC membrane (Pd-BNC). The SEM images of the surface of the Pd-BNC membrane showed
sparse Pd structures formed on the surface with a large fraction of the surface free of Pd
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nanostructures, which may be attributed to the highly dense network structure of pristine BNC
membrane compared to mPDA-BNC membrane (Figure S3.2A, supporting information).
Atomic force microscopy image of the Pd-BNC further confirmed the low coverage of the Pd
nanostructures

on

the

BNC

surface

(Figure

S3.2B,

supporting

information).

The

thermogravimetric analysis of the membranes showed that Pd accounts for 20.3 wt% in PdmPDA-BNC and 13.6 wt% in Pd-BNC (Figure S3.3, supporting information). The higher Pd
loading in Pd-mPDA-BNC compared to pristine BNC membrane shows that the incorporation of
mPDA nanoparticles provides higher density of active sites for the in situ growth of Pd
nanostructures, thereby potentially improving its catalytic properties.
To understand the chemical composition of Pd-mPDA-BNC membrane, we performed X-ray
photoelectron spectroscopy (XPS) measurements. The binding energy of Pd 3d5/2 and Pd 3d3/2
obtained from the Pd-mPDA-BNC at 333.0 and 338.3 eV can be assigned to Pd (0), indicating
the metallic form of Pd. The peaks at 334.1 and 339.1 eV correspond to the oxidized form of Pd
(Pd2+) (Figures 3.2G, Figure S3.4, supporting information).144-145 The Pd(0):Pd(II) ratio is
calculated to be around 19.5:10, indicating that a major fraction of Pd in the Pd-mPDA-BNC
membrane exists in the metallic form.146 Energy-dispersive X-ray spectroscopy (EDS) analysis
further confirmed the presence of Pd in the membrane with strong peaks at 2.85 eV and 3.01
KeV (Figure 3.2H). Furthermore, the presence of Pd nanoparticles in the membrane was also
verified by X-ray diffraction (XRD). The XRD pattern exhibited four peaks at 40.2°, 46.7°, 68.3°
and 82.1° corresponding to the (111), (200), (220) and (311) planes of typical face centered cubic
Pd, respectively (Figure 3.2I).147
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3.2.2 Batch Reaction for Wastewater Treatment
The mPDA nanoparticles are used instead of PDA because they provide nanopores for Pd
nucleation (Figure 3.2) and higher surface area for efficient adsorption of organic dyes. Figure
S5 demonstrates the superior performance of mPDA particles compared to PDA particles with
improved dye removal efficiency for all three dyes at all pH values tested. As a proof-of-concept
for degradation efficiency, we evaluated the dye removal efficiency of the Pd-mPDA particles.
Methyl orange (MO, anionic dye), 4-nitrophenol (4NP, neutral) and methylene blue (MB,
cationic dye) were selected as model dyes. The dye removal efficiency of the Pd-mPDA and
mPDA particles were compared under a wide range of environmentally relevant pH conditions.
Polydopamine is not stable at extremely acidic or alkaline solutions, hence, pH values from 3 to
9 were chosen for the dye removal experiments.148 Polydopamine adsorbs positively charged
organic dyes mainly through electrostatic interactions above pH 4.130 However, the adsorption
efficiency is low for negatively charged and neutral dyes above pH 4, which is attributed to the
negatively charged surface of PDA under these conditions (isoelectric point of PDA is 3.2).130
We hypothesized that this low efficiency can be overcome by incorporating catalytically-active
Pd nanoparticles in mPDA nanoparticles. The dye removal mechanism of mPDA is exclusively
through adsorption, while that of Pd-mPDA nanoparticles is through the synergistic effect of
adsorption and catalytic degradation. The chemical degradation of dye in presence of catalyst
involves the adsorption of borohydride ions (BH4 -1) on the surface of the catalyst, releasing
hydrogen on its surface. This in turn forms catalyst-H complexes on the surface of the catalyst as
follows149-151:
(3.1)
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(3.2)
Where, C represents the catalyst. The dye molecules then adsorb on the surface of catalyst via
hydrogen bonding. After the adsorption of dye, the catalyst surface transfers the electron from
reducing agent (NaBH4 in this case) to the dye molecules, thereby facilitating the degradation of
dye.152-153 The degradation product is then desorbed from the surface of the catalyst and diffuses
to the bulk region, thereby evacuating the catalytically active site for next reduction run.154
Sodium borohydride reacts with water to form sodium borate, both of which are toxic and should
not exist in water in large amounts.151 Although most studies reporting catalytic degradation of
organic dyes use sodium borohydride as reducing agent, its concentration should be carefully
considered to minimize the possible adverse effect on the environment and human health (more
information on environmental impact of sodium borate is provided in Supporting
Information).155
The catalytic degradation of methyl orange results in the formation of sulfanilic acid and
aromatic amines,156-159 degradation of methylene blue results in leucomethylene blue149-150, 152-153
and that of 4-nitrophenol results in 4-aminophenol.160-162 The byproducts of the catalytic
degradation are colorless and have various industrial and medicinal applications, although toxic
in higher amounts.149-150, 152-154, 156-158, 160-162 This suggests that the processed water can be utilized
by industries for the manufacture of commercially relevant products.162 The reaction kinetics
were monitored using UV-vis spectroscopy. The MO, 4NP and MB exhibit absorption peaks at
465 nm, 400 nm, and 664 nm, respectively (Figure 3.3A, B and C). The MO removal efficiency
for mPDA nanoparticles decreased with increasing pH, which results in an increase in the
negative surface charge of mPDA nanoparticles, thus weakening the electrostatic adsorption of
negatively charged dye (Figure 3.3D). However, the Pd-mPDA nanoparticles in the presence of
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NaBH4 exhibited removal efficiency above 99% at all pH conditions, which can be attributed to
the synergistic effect of electrostatic adsorption and catalytic dye degradation. In the case of
neutral dye 4NP, removal efficiency for mPDA nanoparticles was below 10% at all pH values,
however, the Pd-mPDA nanoparticles exhibited more than 99% removal efficiency at all pH
conditions (Figure 3.3E). The removal efficiency of positively charged MB increased with pH in
case of mPDA nanoparticles due to favorable electrostatic interactions between mPDA
nanoparticles and MB at higher pH values (Figure 3.3F). In other words, the MB removal
efficiency of pristine mPDA nanoparticles was lower under low pH conditions. On the other
hand, the Pd-mPDA nanoparticles exhibited removal efficiency above 99% at all pH values
tested. These results systematically demonstrate that incorporation of catalytically active species,
such as Pd nanoparticles, with mPDA nanoparticles renders synergistic effect of dye adsorption
and degradation, thus significantly improving the overall dye removal efficiency. It is known that
sodium borohydride decomposes at different rates in water at different pH. At pH around 10,
sodium borohydride is more stable in water. At pH around 7, decomposition rate is much faster
(two orders of magnitude) compared to the rate of reaction at pH 10.163 But, this should not
affect the degradation process in our experiments, since all the elements needed for degradation
are already available when sodium borohydride is introduced to the solution. This way, sodium
borohydride decomposition will help degradation of the dye in presence of catalyst (Pd) at all pH
values as is evident from high removal rate (above 99%) for all dyes at all pH values (Figure
3.3).

Having established the synergistic effect of mPDA and Pd nanoparticles, we set out to explore
the reaction kinetics of catalytic dye degradation of Pd-mPDA-BNC membrane. For this, a 1x1
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cm2 piece of Pd-mPDA-BNC membrane was immersed into MO, 4NP and MB dye solutions
containing NaBH4 (see Experimental section for details). Subsequently, the change in
absorbance of each dye was monitored to track the kinetics of the reaction. For MO, the
absorption peak at 465 nm decreased rapidly in the first minute and then the rate of change in
absorbance decreased (Figure 3.4A). The absorbance continued to decrease slowly due to dye
degradation until the solution became completely colorless (not shown in the plot). The MO
solution containing NaBH4 without the Pd-mPDA-BNC membrane did not show any sign of
color change, indicating the need for the catalyst in the degradation reaction (Figure S3.6,
supporting information). For comparison, we have also introduced BNC and mPDA-BNC
membranes (1x1 cm2) and immersed into the MO solution containing NaBH4. However, we
noted only small decrease in the absorbance (11%) after 30 minutes, suggesting that without the
presence of Pd as catalyst, the degradation reaction proceeds at an extremely slow rate. The
batch degradation experiment for 4NP showed similar behavior with Pd-mPDA-BNC membrane
degrading the 4NP rapidly during first two minutes followed by slower rate until complete
degradation (Figure 3.4B). The BNC and mPDA-BNC membranes did not result in any
noticeable change in the 4NP absorbance confirming the catalytic degradation of 4NP in the
presence of Pd nanostructures. The degradation kinetics of MB were significantly different
compared to the former two dyes in that it exhibited significantly smaller slope but linear
degradation over a longer time scale (Figure 3.4C). The significantly different degradation
kinetics of MB compared to MO and 4NP possibly stems from the electrostatic attraction
between positively charged MB and negatively charged BNC and mPDA .130 In addition to
electrostatic adsorption of MB on negatively charged surface, the constant flux of dye molecules
towards the membrane facilitates catalytic degradation. As a result, absorbance of corresponding
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to MB completely disappeared within 5 min, which is in stark contrast to the other two dyes
tested.

To demonstrate the advantage of using mPDA-BNC composite membrane as the template to
grow Pd nanostructure, we investigated the catalytic activity of pristine BNC membrane
containing in situ grown Pd nanostructures. For all three dyes, the degradation trend was similar
to the Pd-mPDA-BNC, however, with a slower reaction rate. Use of mPDA-BNC as a template
improved the degradation speed owing to the larger surface area mPDA nanostructures, which
facilitated higher Pd nanostructures loading (20% by weight) compared to pristine BNC (13% by
weight). The Langmuir–Hinshelwood apparent first-order kinetics was used to estimate and
compare the reaction rate constant for different dyes and substrates (Figure 3.4D, E and F). From
pseudo first-order kinetics analysis, the rate constant of Pd-mPDA-BNC membrane was higher
than Pd-BNC membrane for all three dyes. By using the mPDA-BNC as the template to grow the
Pd nanostructures, the rate of the reaction increased by ~100% for all three dyes, suggesting the
effectiveness of the Pd-mPDA-BNC in improving the catalytic degradation efficacy.

3.2.3 Membrane Filtration
Now, we turn our attention to the possible application of the Pd-mPDA-BNC membrane as a
filtration membrane for treatment of organic dye-polluted water. To test this, the membranes
were placed in a benchtop filtration setup under 0.8 bar vacuum pressure. For each dye, varying
concentrations of dye contaminated water (from low to high) were filtered through the
membranes. Subsequently, the change in absorbance of the dye-contaminated water upon
filtration was used to calculate the dye removal efficiency.

For MO, the filtered water was

completely colorless until 50 ppm with removal efficiency above 99%. Although above 50 ppm
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(extremely toxic concentrations) the filtration efficiency gradually decreased, the membrane was
still able to remove more than 92% of the MO at 200 ppm (Figure 3.5A). For comparison, 50
ppm MO solution containing NaBH4 was filtered through the pristine BNC membrane with
removal efficiency of only 20% (Figure S3.7A, supporting information). In the absence of
NaBH4, Pd-mPDA-BNC membrane used to filter 50 ppm MO solution, resulted in only 17%
removal efficiency, highlighting the need for presence of both NaBH4 and Pd nanostructures for
high removal efficiency (Figure S3.7B, supporting information). It is worth noting that the dye
removal efficiency decreases with an increase in the water flux.135,
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Although the effect of

water flux is not systematically studied here, we noted that by increasing the porosity of the
membrane (freeze-drying instead of air-drying), water flux increased, and the degradation
efficiency decreased, possibly due to the shortened time of interaction between catalyst and dye.

In the case of 4NP, the Pd-mPDA-BNC membrane removed more than 99% of the contaminant
until 100 ppm. The removal efficiency gradually decreased for higher concentrations but
remained above 94% up to 200 ppm (Figure 3.5B). For MO and 4NP, the dye removal is caused
mainly by catalytic degradation with little or virtually no contribution from dye adsorption.
However, in the case of MB, adsorption on Pd-mPDA-BNC also contributes to the overall
removal efficiency. The Pd-mPDA-BNC exhibited significantly higher removal efficiency for
MB with 99% dye removal efficiency until 300 ppm (Figure 3.5C). It was only at 400 ppm MB
concentration that the removal efficiency dropped to 95%. These results indicate the excellent
dye removal efficiency of Pd-mPDA-BNC, stemming from the synergistic effect of catalytic
degradation and adsorption of three different classes of organic dye molecules. We observed that
when Pd-mPDA-BNC membrane is subjected to solution containing dye but without sodium
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borohydride, membrane surface turned to blue color, indicating the formation of organic film on
the membrane. However, in the presence of sodium borohydride, due to the catalytic degradation
of the MB, no significant change in the color of the membrane was observed.

Next, we investigated the recyclability of Pd-mPDA-BNC membranes by washing them with
water and alcohol mixture and reusing them for filtration of 50 ppm MO solution.165-166 The
membranes retained their removal efficiency above 96% even after 5 cycles of washing/filtration
steps (Figure 3.5D). Furthermore, in order to explore if the removal happens preferentially for
certain dyes, a 50 ml cocktail containing MO, 4NP and MB (10 ppm of each dye) in presence of
NaBH4 was filtered through a regenerated Pd-mPDA-BNC membrane (Figure 3.5E). All the
dyes were effectively removed from the solution and solution turned colorless from its original
green color (Figure 3.5F).

For real world applications involving regular filtrations and mechanical agitations, the structural
integrity of the membrane is critical. To assess their mechanical stability, Pd-mPDA-BNC
membranes were subjected to 30-day mechanical agitation and 1-day harsh ultrasonication. The
membrane structure compared to that of the pristine Pd-mPDA-BNC membrane and supernatant
color were examined (Figure 3.6A). After 30-day mechanical shaking, there is no sign of particle
leakage and damage to the membrane (Figure 3.6B). However, after 1-day of harsh
ultrasonication, a small amount of the Pd nanostructures leaked from membrane into the solution
as evidenced by the color of the solution (Figure 3.6C).

Ultrasonication is an extreme case, which rarely happens in real-world applications. TGA curves
after mechanical shaking showed no signs of weight change in the membrane confirming the
44

negligible leakage of Pd (Figure 3.6D). However, after 1-day sonication, there was ~3% weight
loss in the membrane, indicating Pd loss during the process. Furthermore, to assess the amount of
Pd loss during the mechanical shaking, the Pd concentration in the supernatant of Pd-BNC and
Pd-mPDA-BNC membranes was measured by inductively coupled plasma mass spectrometry
(ICP-MS) (Figure 3.6E). The presence of trace amount Pd in the supernatant (122 ppb for PdmPDA-BNC and 305 ppb for Pd-BNC) suggest that although there was no measurable weight
loss in TGA curves, small fraction of Pd particles leached out during the shaking. These results
also indicate that Pd-mPDA-BNC is more stable compared to Pd-BNC, yet another advantage of
the composite membrane compared to pristine BNC. The BNC membrane consists of a tightly
packed matrix of cellulose nanofibers and Pd nanoparticles only form on the surface of the BNC
(Figures 3.2D and S3.2). Hence, the Pd nanostructures that are formed on the surface are not
mechanically interlocked and are prone to desorption during mechanical agitation. On the other
hand, the mPDA-BNC membrane structure is more porous with Pd nanostructures covering the
entire surface of cellulose nanofibers and mPDA particles (Figure 3.2F). The Pd nanostructures
interact with both PDA particles and the BNC fibers, which serve as anchoring sites to resist
desorption during mechanical agitation.
Considering the importance of metallic Pd in the dye degradation, XRD spectra was collected
before and after the dye degradation filtration experiments (Figure 3.6F). The virtually identical
XRD spectra before and after filtration further confirmed the stability of the Pd nanostructures in
the membrane. The pore size of the Pd-mPDA-BNC membrane was assessed by filtering 5 nm
gold nanoparticles solution (Figure S3.8, supporting information).44, 130 The filtered solution is
free of gold nanoparticles with rejection rate of ~100% as determined using UV-vis extinction
spectra, indicating that membrane pore size to be smaller than 5 nm. Furthermore, it is expected
45

from the combined observations of SEM images (Figure 3.2 and Figure S3.2) and particle
rejection test that the pore size distribution is in the range of few nanometers to few tens of
nanometers. Hence, the Pd-mPDA-BNC membrane falls in the category of ultrafiltration
membrane. Finally, the water flux through the Pd-mPDA-BNC membrane was measured to be
137.4 L m-2 h-1 under 0.8 bar vacuum pressure. This is much higher than ~ 15 L m-2 h-1 at 4 bar
which we observed from the commercially available color reduction ultrafiltration membrane
(YMGESP3001, Sterlitech) which we tested in our previous study (with 95.2% removal
efficiency for 10 mM MO).44

3.3 Conclusion
In conclusion, we demonstrated a highly efficient organic dye removal membrane based on BNC
loaded with mPDA and Pd nanoparticles for wastewater treatment. Key factors which enable the
Pd-mPDA-BNC membrane to be effective in dye removal are as follow: synergistic effect of dye
adsorption on mPDA and catalytic ability of Pd nanoparticles in presence of NaBH4; highly
porous structure due to the addition of mPDA nanoparticles, which increases the specific surface
area for higher adsorption and degradation; and uniform and high loading of Pd nanoparticles
within the entire membrane. The membrane fabrication process is simple and is easily scalable.
The Pd-mPDA-BNC membrane exhibited excellent dye removal performance (above 99%
removal for MB even at extremely high concentration of 300 ppm) as well as the ability for the
treatment of multiple contaminants with different chemical structures and charge simultaneously.
The membrane exhibited significantly higher water flux (137.4 L m-2 h-1) compared to
commercially available membranes even under low vacuum pressure of under 0.8 bar. The facile
and the scalable fabrication of the membrane along with excellent dye removal efficiency and
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higher water flux makes it a highly attractive candidate for wastewater treatment even at
industrial scales.

3.4 Experimental Section
Materials: 1,3,5-trimethylbenzene (TMB), block copolymer F-127 (Pluronic F-127), dopamine
hydrochloride, 30% ammonium hydroxide solution, glucose, sodium borohydride (NaBH4),
palladium chloride (PdCl2), methyl orange, 4-nitrophenol and methylene blue were purchased
from Sigma-Aldrich. Yeast extract, peptone and disodium phosphate were purchased from Fisher
Scientific and citric acid was purchased from Alfa Aesar. Gluconacetobacter hansenii was
obtained from ATCC (ATCC® 53582). 190 proof ethanol was obtained from Decon Labs, Inc.
All the chemicals were used with no further purification. Nanopure water (≥18.2 MΩ) was used
for the preparation of all solutions unless otherwise stated.
Synthesis of mesoporous polydopamine particles: Mesoporous polydopamine (mPDA)
particles with radially oriented mesoporous channels were synthesized via emulsion-induced
anisotropic assembly technique.136 In a typical synthesis, 1.5 g of dopamine hydrochloride, 1 g of
the block copolymer F-127 and 2 ml of TMB were dispersed in 100 ml of 1:1 ethanol-water
mixture via ultrasonication to form an emulsion. To this emulsion solution, 3.75 ml of 30%
ammonium hydroxide solution was added dropwise under moderate stirring. The mPDA
particles were collected via centrifugation after 2 hours and washed three times with water and
ethanol. Then the particles were redispersed in 20 ml of 1:1 ethanol-water mixture and heated at
100 oC for 24 hours in a sealed Teflon-lined autoclave to stabilize the mesostructure. The
resulting mPDA particles were washed three times with ethanol and water and then redispersed
in water for further use.
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Synthesis of Pd decorated mDA particles: The mPDA particles were dispersed in PdCl2
solution (2.5 wt% in 5 wt% of HCl) and incubated for 2 hours, followed by washing in water to
remove excess PdCl2. Subsequently, Pd2+ ions were reduced to metallic Pd in NaBH4 solution
(100mM) for 10 min to achieve in situ formation of Pd nanoparticles on mPDA. The resultant Pd
decorated mPDA nanoparticles were washed three times in water and redispersed in water for
further use.
Fabrication of mPDA-BNC membrane: The fabrication technique introduced in our previous
work was employed with slight modifications to synthesize mPDA-BNC membrane.130
Gluconacetobacter hansenii (ATCC®53582) was cultured in test tubes containing 16 ml of
#1765 medium at 30 °C under shaking at 250 rpm. The #1765 medium was composed of 2%
(w/v) glucose, 0.5% (w/v) yeast extract, 0.5% (w/v) peptone, 0.27% (w/v) disodium phosphate,
and 0.5% (w/v) citric acid. The as synthesized mPDA particles (14 ml of 0.1 wt%) was
centrifuged and redispersed in #1765 medium and centrifuged again to obtain a wet mixture of
mPDA and medium after decanting the supernatant. Subsequently, this wet mixture was
dispersed in a mixture of Gluconacetobacter hansenii culture solution and fresh medium (2 ml
and 12 ml, respectively). This mixture was then transferred to a petridish (6 cm diameter) and
left undisturbed at room temperature for 2 weeks. The membrane fabrication process can be
modified to significantly reduce the fabrication time to around three days. 44 After 2 weeks, the
mPDA-BNC hydrogel was first washed in boiling water for 6 hours and then dialyzed in
nanopure water for 1 day. Then the cleaned mPDA-BNC hydrogel was air dried in an oven at 60
o

C for 12 hours to obtain mPDA-BNC membrane. Pristine BNC membrane was also obtained

using an identical procedure except for the addition of mPDA particles.
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Formation of Pd Nanostructure on mPDA-BNC membrane: The mPDA-BNC membrane
was immersed in PdCl2 solution (2.5 wt% in 5 wt% of HCl) and incubated for 1 hour. This PdCl2
soaked membrane was then immediately immersed in 100 mM NaBH4 solution for 10 min to
achieve in situ formation of Pd nanoparticles on membrane fibers and mPDA surface. The
obtained Pd-mPDA-BNC membrane was then air dried in an oven at 60 oC for 2 hours.
Materials Characterization: Scanning electron microscopy (SEM) images were obtained by
using a JEOL JSM-7001 LVF Field Emission scanning electron microscope at an accelerated
voltage of 10kV. Transmission electron microscopy (TEM) images were obtained using JEM2100F (JEOL) field emission STEM at an operating voltage of 200 kV. X-ray photoelectron
spectroscopy (XPS) analysis was performed using Physical Electronics® 5000 VersaProbe II
Scanning ESCA (XPS) Microprobe. The X-ray diffraction (XRD) patterns of the membranes
were obtained using a Bruker D8-Advance X-ray powder diffractometer using Cu Kα radiation
(λ = 1.5406 Å). TGA was performed in nitrogen atmosphere using a TA Instruments Q5000 IR
Thermogravimetric Analyzer at a heating rate of 10 oC/min. The optical absorption spectra of
dye-contaminated water were obtained using a Shimadzu UV-1800 UV-Vis spectrometer. Trace
amounts of Pd was measured using ICP-MS: PerkinElmer NexION 2000 in duplicates of three
different dilutions and the average of all 6 measurements was reported.
Evaluation of dye removal performance of Pd-mPDA particles: The dye removal
performance of Pd-mPDA particles was evaluated by incubating Pd-mPDA particles (200 µg/ml,
final concentration) with dye-contaminated water (10 ppm, final concentration) in the presence
of NaBH4 (1.2 mM, final concentration) at different pH (3,5,7,9) under constant stirring. In these
experiments, pH of the dye solution was adjusted to desired value using NaOH or HCl, then it
was mixed with Pd-mPDA nanoparticles, followed by addition of the NaBH4. After 10 minutes,
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the mPDA particles were centrifuged down and the optical spectra of the dye solutions before
and after the particle incubation was monitored. The dye removal efficiency of the particles was
calculated using the following equation:

(3.3)

Where, co and cf are the initial and final dye concentration, Ao and Af are the initial and final dye
optical absorbance, respectively.
Evaluation of catalytic kinetics of Pd-mPDA-BNC membrane: The catalytic kinetics of the
Pd-mPDA-BNC membrane was evaluated by monitoring the evolution of catalytic dyedegradation reaction with time. NaBH4 (1.5 mM, final concentration) was rapidly added into the
dye solution (15 ppm, final concentration) under constant stirring and subsequently, Pd-mPDABNC membrane (1 cm X 1 cm) was placed in 1.5 ml of the above solution to initiate the catalytic
reaction. The concentration of the reactant (dye) obtained from UV-Vis spectra of the solution
was monitored every 30 sec for 11 minutes. The rate constant of the degradation reaction of dye
using Pd-mPDA-BNC as a catalyst was estimated via Pseudo-first-order kinetics as follows:167

(3.4)

Where, co is the initial reactant concentration, ct is the reactant concentration at time t, k is the
reaction rate constant and t is the reaction time. In this reaction, the ratio of ct and co was
calculated from the relative absorbance intensity of At/Ao.
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Evaluation of dye removal performance of Pd-mPDA-BNC ultrafiltration membrane: The
dye removal performance of the Pd-mPDA-BNC ultrafiltration membrane was evaluated via
filtering dye-contaminated water through the membrane using a benchtop vacuum filtration
setup. The diameter of all the membranes used in vacuum filtration is 3 cm. 10 ml of varying
concentrations of dye solutions (0 – 200 ppm) were filtered through the membrane placed in a
benchtop vacuum filtration setup under 0.8 bar in the presence of NaBH4 (2.5 mM, final
concentration). The optical absorption spectra of the solutions before and after filtration was
monitored and the dye removal efficiency of the membrane was calculated as follows:

(3.5)

Where, Ao is the initial dye optical absorbance and Af is the final dye optical absorbance after
filtration.
Flux and particle rejection test: Water flux of the Pd-mPDA-BNC membrane was estimated
using a benchtop vacuum filtration setup under 0.8 bar by filtering 200 ml of water through a
fixed cross-section area of membrane and the total time for filtration was recorded. The water
flux was calculated as follows:

(3.6)

Gold nanoparticles (AuNPs) with a diameter around 5 nm were synthesized using previously
reported successive seed-mediated growth synthesis.168 10 ml of the as-synthesized AuNP
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solution was then filtered through Pd-mPDA-BNC membrane using the above mentioned
benchtop vacuum filtration setup under 0.8 bar. The optical extinction spectra of feed and
permeate solutions were monitored and the rejection rate was determined as follows:

(3.7)

Where, Ef and Ep are the optical extinction of feed and permeate solutions, respectively.

3.5 Supporting Information
Supporting Information for chapter 3 is provided in appendix 2.
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3.6 Figures

Figure 3. 1 Schematic illustration showing the preparation of the catalllically active Pd-mPDABNC membrane. Bacteria produces cellulose nanofibers in the presence of the mPDA particles to
create mPDA-BNC hydrogel. The mPDA-BNC hydrogel is incubated in PdCl2 solution,
subsequently transfereed to NaBH4 solution to create metalic palladium nanostructures on the
cellulose fibers and mesoporous polydopamine nanoparticles.
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Figure 3. 2 Transmission electron micrographs of (A) mesoporous polydopamine nanoparticles
and (B) palladium nanoparticle (Pd NP)-loaded mesoporous polydopamine nanoparticles (black
dots represent Pd nanoparticles). (C) HRTEM image of a single Pd NP on the mPDA
nanoparticle. Scanning electron micrographs of top surface of the (D) BNC membrane, (E)
mPDA-BNC membrane and (F) Pd NP-loaded mPDA-BNC membrane. (G) XPS spectra of Pd
3d peak after reduction of Pd on the mPDA-BNC membrane. (H) EDX spectrum of Pd-mPDABNC showing the formation of metallic palladium. (I) XRD spectrum of the Pd-mPDA-BNC
membrane showing the peaks corresponding to palladium nanocrystals.
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Figure 3. 3 UV–vis spectra showing the degradation of (A) MO, (B) 4NP and (C) MB in the
presence of NaBH4 and Pd-mPDA nanoparticles at pH=7. Dye removal performance of the
pristine mPDA and Pd-mPDA nanoparticles at different pH for different dyes: (D) negatively
charged methyl orange (MO), (E) neutral 4-nitrophenol (4NP) and (F) positively-charged
methylene blue (MB) (insets show the chemical structure of each dye molecule).
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Figure 3. 4 Plots showing the degradation of different membranes for (A) MO, (B) 4NP and (C)
MB in the presence of NaBH4 over time. Langmuir–Hinshelwood apparent reaction rate constant
for degradation of (D) MO, (E) 4NP and (F) MB in the presence of Pd-mPDA-BNC and PdBNC.
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Figure 3. 5 Dye removal efficiency of Pd-GO-BNC membrane at different (A) MO, (B) 4NP and
(C) MB concentrations. (D) Dye removal efficiency of the Pd-mPDA-BNC membrane over
multiple cylces of filtration/regenarations showing the reusability of the membranes. (E) UV–vis
spectra showing the dye removal from a cocktail (50 mL) of organic contaminants: MO, 4-NP,
and MB (each with a concentration of 10 ppm) in the presence of NaBH4 (2.5 mM). (F)
Photographs showing the organic dye cocktail before and after filtration treatment.
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Figure 3. 6 Optical images of (A) Pristine Pd-mPDA-BNC membrane, (B) after 30-day
mechanical shaking and (C) after 1-day ultrasonication. (D) TGA of pristine Pd-mPDA-BNC,
after 30-day mechanical shaking and 1-day sonication showing the Pd particle loss percentage
during the process. (E) Concentration of Pd leaked into solution after mechanical shaking of PdBNC and Pd-mPDA-BNC membranes showing better stability of the latter membrane compared
to the former. (F) The XRD spectra before and after the dye degradation filtration experiment
showing the intact Pd nanocrystals, which serve as the catalyst.
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Chapter 4: Polydopamine-Mesoporous Silica CoreShell Nanoparticles for Combined PhotothermalImmunotherapy
4.1 Introduction
Immunotherapy has proven to be a successful therapeutic approach for cancer with long-lasting
effects. However, only a limited fraction of patients is completely cured by standalone
immunotherapy. A primary cause of the low response rate is the “immunoediting” employed by
cancer in an immuno-competent host to escape surveillance.169-171 Cancer cells downregulate
antigenic proteins and peptides, upregulate immune-inhibitory receptors and express/secrete
immuno-suppressive factors to effectively create a pro-tumor microenvironment.172 The primary
goal of immunotherapeutic interventions is to restore the lost immunogenicity and reverse the
immuno-suppressive microenvironment in the tumor.173-174 Toll-like receptor (TLR) agonists and
immunomodulatory vaccine adjuvants such as polyinosinic:polycytidylic acid (Poly(I:C)),
cytosine-phosphorothioate-guanine (CpG), imiquimod, and resiquimod reprogram the tumor
microenvironment (TME). These TLR agonist act either alone or in combination with other
treatment modalities such as chemotherapy, photodynamic therapy (PDT), radiotherapy or
photothermal therapy (PTT) for generation of potent anti-tumor immune response.175-180
An ideal combination immunotherapy involves a “tumor killing” modality including PTT, PDT,
or chemotherapy, that should partially ablate the tumor and release tumor-associated antigens
(TAAs) and damage associated molecular patterns (DAMPs). The released TAAs and DAMPs
synergize with immunomodulatory drugs to create a tumor-inhibitory environment. In previous
studies, the two components-i) chemo/photothermal/photodynamic agents; and ii) the
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immunomodulators, are co-delivered either in the form of a simple physical mixture or coencapsulated in a drug delivery vehicle.181-185 With these therapeutic approaches, there is no
external control over the release profile or the bioavailability of the therapeutic agents once the
formulation is administered inside the body. The lack of external control over the cargo release
leads to differential release kinetics of antigen and adjuvant. This compromises the efficacy of
the innate immune response and subsequent adaptive immune response. For eliciting cytotoxic
anti-tumor immune response, the internalized antigen must undergo cross-presentation, which
includes MHC I-restricted presentation to CD8+ T cells.186-187 For optimum cross-presentation by
APCs, the antigen and adjuvant should preferentially be exposed simultaneously to the APCs.188
If the APCs are exposed to adjuvant first, it leads to their activation and maturation, which in
turn leads to down-regulation of phagocytosis and cross-presentation compromising the overall
anti-tumor immunity.189-190 On a contrary, if the APCs are exposed to antigen first in the absence
of adjuvants, then the APCs cross-present the antigen in the absence of co-stimulatory receptors
(e.g., CD40, CD80), which leads to generation of immunological tolerance and anergy.191-193
Both of these scenarios (antigen first in the absence of adjuvant and vice versa) result in suboptimal anti-tumor immune response, thus underscoring the importance of innovative delivery
approaches for spatiotemporally orchestrating the availability of antigens and adjuvant for APCs.
Here, we aim to achieve concurrent release of antigen and adjuvant by photothermally ablating
the tumor cells for release of TAAs and simultaneously triggering the release of adjuvant.
Towards this goal, we have designed and synthesized polydopamine (core) - mesoporous silica
(shell) nanostructures that enable photothermal tumor ablation owing to the photothermal
properties of the PDA nanostructures and simultaneous release of the adjuvant contained in the
mesoporous silica shell. Recently, polydopamine has attracted increased attention as a bio60

inspired, biocompatible, and biodegradable photothermal material for various biomedical
applications.1,

3, 61-65

Mesoporous silica, which is employed as shell, exhibits excellent

biocompatibility, and complete degradation into non-toxic components making it an attractive
candidate as a drug carrier.66 We harnessed mesoporous silica shell for controlled release of
gardiquimod, a toll-like receptor 7/8 (TLR 7/8) agonist, known to improve cell-based or
combination immunotherapies for various cancers.194-197 Mesoporous silica was loaded with a
mixture of gardiquimod and a phase change material, 1-tetradecanol, which served as a “gate
keeper” for near infrared (NIR) light-controlled release of the cargo. We engineered the coreshell nanoparticles to generate locoregional heat to ablate the tumor cells and simultaneously
release the adjuvant through melting of the phase change material upon heating caused by NIR
irradiation (Figure 4.1A). The concurrently released antigens (upon tumor ablation with NIR
irradiation) and adjuvant causes effectual activation of dendritic cells, which in turn activate the
CD8+ T cells in the tumor draining lymph nodes. The activated cytotoxic effector T cells not
only eliminate the residual primary tumor but also inhibits recurrent secondary tumors (Figure
1B). Using these multifunctional nanoparticles, we demonstrate robust photothermalimmunotherapeutic response using NIR light as an external trigger.

4.2 Results and Discussion
4.2.1 Synthesis and characterization of mesoporous silica-polydopamine
nanoparticles (PDA@mSiO2)
Spherical PDA nanoparticles are synthesized by oxidative self-polymerization of dopamine
monomer in water−ethanol−ammonium mixture at room temperature.10 By controlling the
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amount of ammonium hydroxide, spherical PDA particles with a diameter of 260 ± 32 nm were
synthesized (Figure 4.2A, E).

Subsequently,

silica shell was formed around the PDA

nanoparticles using modified Stӧber method.198 For forming nanoscale pores within the silica
shell, cetyltrimethylammonium bromide (CTAB), which serves as a porogen, was added to the
reaction mixture. Following the formation of the shell, CTAB was removed through ion
exchange.199 The resulting core-shell nanostructures exhibited highly porous structure with
buckled surface (Figure 4.2B, F). The as-prepared silica-coated PDA nanoparticles did not
exhibit buckling on their surface (Figure S4.1). The surface buckles appeared after refluxing the
core-shell particles in ammonium nitrate solution to remove the porogen (i.e. CTAB). The
differential thermal stresses at the core-shell interface developed during reflux process (at 45°C
for 24 hours) possibly result in the buckled surface morphology of the nanostructures. The
thickness of the mesoporous silica coating was found to be ~100 nm as measured by dynamic
light scattering (Figure 4.2C). Both PDA and PDA@mSiO2 exhibited negative zeta-potential (~30 mV) at physiological pH of 7.4 (Figure 4.2D). The pore size distribution of the PDA@mSiO2
nanoparticles exhibited a sharp peak at 3.1 nm, confirming the mesoporous nature of the shell
(Figure 4.2G).

Scanning transmission electron microscopy-energy dispersive X-ray

spectroscopy elemental mapping of N and Si delineated the PDA core and silica shell, as
evidenced by the presence of N and Si in the core and shell, respectively (Figure S4.2).
Thermogravimetric analysis (TGA) of the pristine PDA nanoparticles and PDA@mSiO2
nanoparticles indicated that silica shell corresponds to about 53% of the weight of the
PDA@mSiO2 nanoparticles (Figure 4.2H).
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4.2.2 Photothermal and controlled release properties of PDA@mSiO2
nanoparticles
Polydopamine and PDA@mSiO2 nanoparticles exhibited broad light absorption over visible and
NIR parts of the electromagnetic spectrum (Figure S4.3A). To explore the NIR-induced heating
of PDA@mSiO2 nanoparticles and dynamics of the temperature increase, different
concentrations of PDA@mSiO2 nanoparticles in water were subjected to 808 nm laser irradiation
at a power density of 14 mW/mm2. For 300 seconds of laser irradiation, the temperature
increased monotonically and reached to a maximum of 57°C for PDA@mSiO2 nanoparticles
solution with a concentration of 1000 µg/ml (Figure 4.3A). As expected, the maximum
temperature increased with an increase in the nanoparticle concentration (Figure 4.3B).
Temperature rise of the core-shell nanoparticle solution under NIR irradiation ranged from 10°C
to 30°C for concentrations ranging from 100-1000 µg/ml. In contrast, temperature of de-ionized
water increased by only 2°C under identical NIR irradiation conditions. Following the NIR
irradiation for 20 min, no discernable changes in the shape or pore structure of the core-shell
nanoparticles were observed, indicating the stability and applicability as drug carriers for
controlled release (Figure S4.3B). The photothermal efficiency was calculated and found to be
56.8% (See discussion in Supporting Information).

Next, we investigated the loading and controlled release of cargo from core-shell nanostructures
using 1-tetradecanol as gate keeper. 1-Tetradecanol, a biocompatible phase changing material,
exhibits melting temperature of 38-39°C, which is slightly above the normal human body
temperature. Consequently, 1-tetradecanol can contain the cargo in the nanoparticles at body
temperature with minimal leakage and enable triggered release of the contents by external
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heating.200 A model dye, Rose Bengal (RB), mixed with 1-tetradecanol was loaded into the
nanostructures.

As discussed above, under NIR irradiation, PDA@mSiO2 nanoparticles

exhibited temperature rise, enough to melt 1-tetradecanol and release the cargo. The RB-loaded
PDA@mSiO2 nanoparticles solution was concentrated to 4 mg/ml and subjected to NIR laser (14
mW/mm2) to trigger the release. During the first 5 minutes of the treatment, the solution
temperature raised steadily followed by saturation at ~70°C for the subsequent 15 min of
irradiation (Figure 4.3C). As the temperature increased to above the melting point of the 1tetradecanol within 1 minute, the optical absorbance of RB in the surrounding aqueous medium
started to increase, indicating the NIR-triggered release of the dye from the nanoparticles (Figure
4.3C, D). The cumulative absorbance of the dye steadily increased for the subsequent 20 min
indicating the continuous release of the dye from the nanostructures. In stark contrast, the RBloaded PDA@mSiO2 nanoparticles solution incubated at room temperature (25°C) for 1 day
exhibited a leakage of only 1.5%, which shows their excellent ability to contain and release the
payload only under an external trigger. Successful loading and controlled release of the payload
from PDA@mSiO2 nanoparticles was further confirmed using a fluorescent dye (see Figure
S4.5A and discussion in Supporting Information).

4.2.3 Photothermal therapeutic efficacy and immune-stimulatory effect of
gardi-mPDA nanoparticles
Now we evaluated the in vitro photothermal therapeutic efficacy of the gardiquimod-loaded
PDA@mSiO2 (called gardi-mPDA henceforth) nanoparticles. The encapsulation efficiency of
gardiquimod in nanoparticles was determined to be 11 ± 3 µg/mg (see Experimental section).
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B16-F10 melanoma cells were incubated with different concentrations of gardi-mPDA
nanoparticles, followed by 10 minutes of laser irradiation (14 mW/mm2). For all concentrations
of gardi-mPDA nanoparticles, a significant decrease in viability was observed in NIR treated
cells compared to cells without NIR treatment (Figure 4.3E). Importantly, without NIR
irradiation, no toxicity was observed, indicating that the adjuvant-loaded particles by themselves
are not cytotoxic. For efficient photothermal cytotoxicity the nanoparticles should physically
interact with cancer cells. The nanoparticle-cell interaction was assessed by incubating B16-F10
cells with LT680-loaded PDA@mSiO2 (LT680-mPDA) followed by confocal fluorescence
microscopy. We observed punctate-like LT680 signal from the cells confirming physical
nanoparticle-cell interaction (Figure S4.5B).
After confirming the in vitro photothermal therapeutic efficacy of the gardi-mPDA nanoparticles,
we investigated their immuno-stimulatory potential upon NIR-triggered release of gardiquimod.
Bone marrow derived dendritic cells (BMDCs) were treated with supernatants collected from
gardi-mPDA (100 µg/ml) subjected to 10 minutes of NIR treatment. Concentration of secreted
interleukin 6 (IL-6) and tumor necrosis factor-α (TNFα), which indicate the activation of
BMDCs, were measured and compared to secretion levels of BMDCs treated with free
gardiquimod. There was a significant increase in cytokine secretion following the treatment of
BMDCs with supernatant of NIR treated gardi-mPDA nanoparticles compared to supernatant
without NIR treatment (Figure 4.3F, G). Similar results were observed for upregulation of
maturation markers (CD40 and CD80), where supernatants collected from NIR-treated
nanoparticles led to significant increase in BMDC maturation as compared to without NIR
treatment (Figure S4.4). It is important to note that CD40 and CD80 serve as co-stimulatory
signal for efficient activation of CD8+ T cells. These results indicate that gardiquimod can be
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released with external trigger and the photothermally released gardiquimod is therapeutically
active.

4.2.4 Combined photothermal-immunotherapy effect of gardi-mPDA
nanoparticles
After confirming the in vitro photothermal therapeutic efficacy of PDA@mSiO2 nanoparticles
and immuno-stimulatory effect of gardi-mPDA nanoparticles independently, we set out to
answer two key questions: (i) Does the NIR treatment of cancer cells incubated with gardimPDA nanoparticles release both the TAAs and adjuvant concurrently; and (ii) is the released
adjuvant from the cancer cells capable of causing immunostimulatory effect? To address these
questions, B16-F10 cells were treated with LT680-mPDA and then loaded with a cell-permeable
protein-labelling dye, carboxyfluorescein succinimidyl ester (CFSE). Here, LT680 serves as
model drug loaded in mPDA and CFSE labelled intracellular proteins serve as representative
tumor antigen. The cells were harvested and divided into two groups: with and without NIR
treatment (Figure 4.4A). The supernatants collected from both groups were analyzed for LT680
and CFSE fluorescence. The NIR treatment demonstrated significant increase in fluorescence
intensity of both LT680 and CFSE as compared to without NIR treatment (Figure 4.4B, C).
These results indicate the ability of PDA@mSiO2 nanoparticles to simultaneously release the
loaded drug and protein antigen from the cells when treated with NIR light. Next, we incubated
B16-F10 cells with gardi-mPDA nanoparticles and subjected them to NIR treatment to induce
the release of gardiquimod from internalized and cell surface bound nanoparticles. Subsequently,
BMDCs were treated with the above mentioned B16-F10 cell culture supernatant to assess the
activation ability of the released gardiquimod. Clearly, the cell culture supernatant resulted in
activation of BMDCs as evidenced by the increase in the secreted IL-6 concentration, further
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confirming the NIR-assisted release of gardiquimod from within the cancer cells and its
immunomodulatory effects (Figure 4.4D).

4.2.5 In vivo photothermal efficiency and externally triggered release of
payload
To further investigate the photothermal efficacy of the PDA@mSiO2 nanoparticles in vivo,
subcutaneously inoculated B16-F10 mouse melanoma model was used. One day after the
administration of the nanoparticles, tumors were irradiated with an NIR laser for 5 minutes (laser
power 6 and 14 mW/mm2). Mice without nanoparticle injection were employed as control group.
After laser irradiation at a power density of 14 mW/mm2 for 5 minutes, the tumor temperature for
the control group without nanoparticle injection reached 40°C. In contrast, under identical
irradiation conditions, the tumor temperature for the mouse injected with PDA@mSiO2
nanoparticles, increased to 81 °C, indicating the high photothermal efficiency of PDA@mSiO2
nanoparticles in converting NIR light to heat and inducing locoregional cell ablation (Figure
S4.6A, B). In vivo fluorescence imaging of the tumors after injection of LT680-mPDA revealed
nearly two-fold increase in fluorescence after subjecting the tumors to NIR irradiation for 5
minutes as compared to without NIR treatment, confirming that the dye encapsulated in
nanoparticles, is diffusing outward and restoring fluorescence after successful NIR triggered
release from the nanoparticles (Figure S4.6C, D).

4.2.6 In vivo therapeutic efficacy of gardi-mPDA
After confirming in vitro photothermal therapeutic efficacy and successful release of payload
under NIR irradiation, we investigated the therapeutic potential of gardi-mPDA in vivo. The
release of tumor antigen after photothermal ablation of tumor cells and concurrent release of
67

adjuvant is critical for robust anti-tumor immune response. We employed B16-F10 melanoma
model and intra-tumorally injected the gardi-mPDA nanoparticles followed by NIR treatment
(808 nm, 14 mW/mm2) (Figure 4.5A). The first step was to assess the biocompatibility of
nanoparticles for which the body weight of the mice was monitored. No significant difference
was observed in the body weight of the mice treated with PDA@mSiO2 or gardi-mPDA
nanoparticles indicating that the nanoparticles did not cause any severe systemic toxicity (Figure
4.5B). Tumor growth was monitored for different treatment groups and we noted that the gardimPDA nanoparticles treated with NIR resulted in significant inhibition of tumor growth
compared to gardi-mPDA nanoparticles without NIR, PDA@mSiO2 nanoparticles with NIR and
PBS group (Figure 4.5C). The survival rate of mice treated with gardi-mPDA nanoparticles and
NIR was ~57% at day 43, while all the other groups had 0% survival rate at day 30 (Figure
4.5D). Notably, the tumors for mice treated with PDA@mSiO2-NIR exhibited inhibition in
tumor growth (due to photothermal tumor ablation) until day 10-11 while the tumors for mice
treated with PBS or gardi-mPDA without NIR demonstrated constant growth (Figure 4.5E, F,
G). However, the effect of PDA@mSiO2-NIR was not long-lasting as the tumor cells, which
survived photothermal ablation started growing, ultimately resulting in the formation of tumors
equivalent in size to that of gardi-mPDA group at day 19. Although PDA@mSiO2-NIR group is
expected to release abundant tumor associated antigens during photothermal ablation, the
presence of antigen without adjuvant resulted in sub-optimal therapeutic effect. In the other
control group where the mice were treated with gardi-mPDA, adjuvants were available to tumor
resident antigen-presenting cells (APCs) as the nanoparticles are eventually expected to be
uptaken by APCs followed by their activation (Figure 4.6).
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The gardi-mPDA treated mice showed moderate inhibition in tumor growth, which is possibly
due to the reversal of immuno-suppressive microenvironment in tumor caused by TLR7/8
agonism.201

More specifically gardiquimod is known to impart tumor-killing potential to

plasmacytoid dendritic cells.202 The moderate inhibition of tumor growth observed in mice
treated with PDA@mSiO2-NIR and gardi-mPDA without NIR was not robust and short-lived as
it eventually lead to 100% mortality until day 30. Mice treated with gardi-mPDA-NIR
demonstrated dramatic inhibition in tumor growth emphasizing the role of simultaneous release
of antigen and adjuvant (Figure 4.5H). The released antigen and adjuvants from the
photothermally ablated tumor cells are available to APCs, which are expected to migrate to the
tumor draining lymph nodes where they activate the CD8+ T cells. These effector immune T
cells are capable of eradicating the residual tumors, which survive the primary photothermal
ablation. The mice surviving primary tumor challenge were able to significantly inhibit growth
of secondary tumors indicating the generation of long-term memory response, when compared to
age-matched naïve mice (Figure 4.5I). The biocompatibility of these nanoparticles was further
confirmed by histopathological staining. We observed no signs of cell death, confirming no
systemic toxicity in the visceral organs of the mice after treatment with gardi-mPDA-NIR
(Figure 4.5J).
Since the primary tumors were temporarily attenuated by photothermal effect caused by
PDA@mSiO2-NIR, we reasoned if the increase in NIR treatment duration from 5 minutes to 10
minutes could result in complete ablation of tumor growth without the need for immunotherapy.
We treated the mice with PDA@mSiO2 and gardi-mPDA followed by NIR treatment for 10
minutes (Figure S4.9A). NIR treatment for 10 minutes was well tolerated by mice as it did not
cause any decrease in the body weight of the mice (Figure S5.9B). Interestingly, both
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PDA@mSiO2-NIR and gardi-mPDA-NIR resulted in significant inhibition of tumor growth
(Figure S4.9C). While less than half (40%) of the mice in PDA@mSiO2-NIR group survived at,
80% of mice in gardi-mPDA-NIR survived at day 46 with no observable signs of primary tumor
(Figure S4.9D). In order to evaluate the long-term efficacy of both photothermal therapy and
photothermal-immunotherapy the tumor-free mice from primary challenge were subjected to
secondary tumor challenge on the opposite flank. It was observed that the mice treated with
concurrent photothermal-immunotherapy had better resistance to tumor growth as compared to
just photothermal therapy (Figure S4.9E). Taken together, these results emphasize the
significance of both specificities associated with the tumor-associated antigens and immunestimulatory capabilities of the adjuvant for generation of robust and long-lasting anti-tumor
immune response.

4.2.7 In vivo immune status in tumor draining lymph node
The population and activation status of immune cells in the tumor draining lymph nodes was
assessed to understand the role of immune cells in therapeutic effect. Increased percentage of
both T cells and dendritic cells (DCs) was observed in tumor draining lymph nodes of mice
treated with gardi-mPDA-NIR. Specifically, presence of CD3+CD8+ T cells was analyzed, and
we observed that while PDA@mSiO2-NIR resulted in a modest increase in T cells, gardi-mPDA
nanoparticles irrespective of the presence or absence of NIR resulted in almost two-fold increase
in T cell count compared to PBS (Figure 4.6A). Maturation of DCs was assessed by measuring
the expression levels of maturation markers (CD40, CD80, MHC II). We observed higher
activation of DCs with gardi-mPDA treated groups compared to PDA@mSiO2-NIR or PBS
group. PDA@mSiO2-NIR has relatively mild immuno-stimulatory potential in the absence of
potent adjuvants. Despite having significant immuno-stimulatory effect, the influence of gardi70

mPDA is non-specific because of lack of specific tumor associated antigen (Figure 4.6B, S4.7,
S4.8). This signifies that the presence of both antigen and adjuvant is critical for generation of
long-lasting immune response. Externally triggered NIR facilitated the release of both antigen
and adjuvant simultaneously, thus orchestrating a highly potent tumor-specific immune response.

4.3 Conclusion
To summarize, we designed and synthesized a core-shell nanostructure based on highly
biocompatible and completely biodegradable components, where the photothermal property of
the core was integrated with NIR-responsive drug release properties of the shell for ultimately
generating a robust and long-lasting anti-tumor immune response. PDA nanoparticles were
employed as a photothermal core and mesoporous silica shell was used as the carrier for a
mixture of phase-change material (1-tetradecanol) and immune-stimulating agent (gardiquimod).
These nanoparticles were effectively uptaken by cancer cells and led to concurrent release of
both antigen and adjuvant from the cancer cells upon NIR irradiation. The external trigger NIR
facilitated spatiotemporal control of the therapeutic events for ultimately mounting a potent antitumor immune response. The core-shell nanoparticle design is universal and is amenable for
loading other types of immunomodulatory or chemotherapeutic drugs or their combinations for
synergistic effects. The versatility and unique design of these multifunctional nanoparticles can
be harnessed for improved photothermal-immunotherapeutic treatments acting as a powerful
platform for cancer treatment.

4.4 Experimental Section
Preparation of PDA nanoparticles coated with mesoporous silica shell (PDA@mSiO2): All
chemicals are purchased from Millipore Sigma, St. Louis, MO, USA and used without further
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purification, unless or otherwise mentioned. Polydopamine nanoparticles were synthesized by
using a method reported previously.10 Briefly, 112 mL of ethanol was mixed with 252 mL of
deionized (DI) water (resistivity of 18.2 MΩ·cm) in a glass container. Subsequently, 4.2 mL of
aqueous solution of ammonia (28−30% NH4OH) was added into the above water/ethanol
mixture. After stirring for 30 minutes, dopamine hydrochloride (1.4 g in 28 mL water) was
added to the reaction mixture. The reaction was left under gentle magnetic stirring for 24 hours.
The PDA particles were collected by centrifugation (9000 rpm, 10 minutes) and washed with DI
water five times and dispersed in water.
To form mesoporous silica shell on PDA particles, 0.8 ml of polydopamine solution (8 mg/ml in
water) was mixed with 0.4 ml of cetyltrimethylammonium bromide (CTAB, 0.1 M) and stirred at
30 ºC for 10 minutes. Then, 0.2 ml tetraethyl orthosilicate (TEOS, 17% v/v in ethanol) was
added to the mixture under vigorous stirring. After 10 minutes, 5 µl of ammonium hydroxide
(NH4OH, 30% in water) was added and the mixture was left stirring at room temperature for 15
hours. The core-shell particles were washed three times with water and then three times with
ethanol and dispersed in ethanol. To remove the template of CTAB, particles were dispersed in
ammonium nitrate solution (NH4NO3, 60 ml, 10 mg/ml in ethanol) and refluxed at 45 ºC for 24
hours. The mesoporous silica-coated PDA nanoparticle were washed five times with ethanol and
dispersed in ethanol.
Drug Loading : Loading of drugs into PDA@mSiO2 nanoparticles using 1-tetradecanol (TD) as
gatekeeper was carried out following previous reports with some modifications.203 Typically, 1tetradecanol (4 mg) was mixed with gardiquimod 1-(4-amino-2-ethylaminomethylimidazo-[4,5c]quinolin-1-yl)-2-methylpropan-2-ol (50 µl, 5 mg/ml in ethanol) in a round-bottom glass tube.
The glass tube was heated to 75 ºC under mild stirring and left for 20 minutes. Subsequently,
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PDA@mSiO2 nanoparticle solution (8 mg in 200 µl ethanol) was added to the mixture and
temperature was increased to 90 ºC. The mixture was stirred for about 1 hour until the ethanol
completely evaporated. The particles were resuspended by adding hot water (1 ml, 80 ºC)
followed by sonication for 5 seconds. The mixture was immediately centrifuged (9000 rpm, 10
min) and supernatant discarded. Drug-loaded particles were dispersed in cold water and washed
with water 10 times to remove free drug in solution. The loading amount of gardiquimod was
measured by dispersing the gardiquimod-loaded nanoparticles in acetone followed by 20 minutes
of sonication to extract the gardiquimod and TD into acetone. The UV-vis absorption at 329 nm
was used to estimate the amount of loaded gardiquimod. The drug loading efficiency was
calculated according to the following equation:

=

To load the Rose Bengal and LT680 dyes, similar procedure was followed. The loading amount
for Rose Bengal (UV absorption at 545 nm) was found to be 11.25 µg/mg.
Nanoparticle characterization
Transmission electron microscope (TEM) images were obtained using a JEOL JEM-2100F field
emission microscopy. Scanning electron microscopy (SEM) images were obtained using a JEOL
JSM-7001 LVF field-emission scanning electron microscope. High resolution transmission
electron microscope (HRTEM) images and EDX elemental mappings were obtained using a
JEOL JEM-2100F field-emission STEM. Thermogravimetric analysis (TGA) was performed in
nitrogen using a TA Instruments Q5000 IR thermogravimetric analyzer at a heating rate of 5 ºC
minute-1. Dynamic light scattering (DLS) and zeta potential measurements were performed using
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Malvern Zetasizer (Nano ZS). Shimadzu UV-1800 spectrophotometer was employed for light
absorption measurements. The pore size distribution was estimated from nitrogen adsorption/
desorption isotherms by using Barrett-Joyner-Halenda (BJH) method and a surface area analyzer
(Autosorb-1C).
NIR-induced heating and drug release profiles
Aqueous solutions of pristine PDA@mSiO2 nanoparticles at different concentrations (0-1000
µg/ml) were prepared in a 1 ml cuvette. NIR laser (808 nm) was placed on top of the cuvette at a
distance of ~10 cm to deliver 14 mW/mm2 power density to the top of the solution. The
temperature rise for different particle concentrations was monitored over 9 minutes by an IR
camera (ICI 7320 USB camera). Temperature rise of water under identical irradiation conditions
was recorded for comparison.
For probing the NIR-triggered release profile, Rose Bengal (RB) was used as a model dye. 1 ml
of RB-loaded PDA@mSiO2 nanoparticles was concentrated to 400 µl solution. 200 µl of the
concentrated particles was irradiated by NIR laser (808 nm) at power density of 14 mW/mm2. At
specific times during laser treatment, 15 µl of the solution was extracted and diluted to 400 µl in
water and centrifuged immediately. The optical absorbance of RB within the supernatant was
measured using UV-vis spectrometer. The corresponding solution temperature for each time
point was measured using an IR camera. Similar procedure was followed for NIR-triggered
release of LT680 (fluorescent dye) from PDA@mSiO2 nanoparticles. The LICOR Odyssey CLx
scanner was used to measure the fluorescence intensity of the supernatant.
Cell culture, BMDC isolation and animal model
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The B16-F10, a murine melanoma cell line, was purchased from American type culture
collection (ATCC). Cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM,
Gibco) with 10% fetal bovine serum (FBS, Gibco), 100 U/ml penicillin and 100 µg/ml
streptomycin. Female C57BL/6 (H-2b) mice that were 6 to 8 weeks of age were purchased from
Jackson Labs (Bar Harbor, ME, USA). The mice were maintained under pathogen-free
conditions. All experiments employing mice were performed in accordance with laboratory
animal protocol approved by the School of Medicine Animal Studies Committee of Washington
University in St. Louis. Mouse were euthanized using CO2 asphyxiation and cervical dislocation.
The euthanized mouse was kept in 70% (v/v) ethanol for 1 min. Both the femurs and tibiae were
isolated, and the muscle attachments were carefully removed using gauze pads. Both ends of the
bones were cut with scissors and the marrow was centrifuged in an adapted centrifuge tube (0.6
ml tube with a hole inserted in 1.5 ml tube) at 1000 rpm for 10 seconds. The pellet was
resuspended by vigorous pipetting in RPMI 1640 media. The cells were passed through a 70 μm
cell strainer to prepare a single cell suspension. After one wash (1200 rpm, 5 min), red blood
cells were depleted with RBC lysis buffer (Sigma-Aldrich). The bone marrow cells were
collected and cultured in 100-mm Petri dishes containing 10 ml RPMI medium supplemented
with 10% heat-inactivated FBS, 50 IU/ml penicillin, 50 μg/ml streptomycin, and 20 ng/ml mouse
recombinant granulocyte- macrophage colony-stimulating factor (GM-CSF, R&D Systems, MN,
USA).
Photothermal cytotoxicity assay
For probing the photothermal efficacy of PDA@mSiO2 nanoparticles, 1x104 B16-F10 cells in
100 µl of media/well were seeded in a 96-well plate and kept at 37oC with 5% CO2 for 12 hours.
Cells were incubated with different concentrations of PDA@mSiO2 nanoparticles for 6 hours
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after which they were subjected to 808 nm laser for 10 minutes at a power density of
14mW/mm2. After 24 hours, MTS assay was performed as per manufacturer protocol.
BMDC activation and maturation
BMDCs (1x106) were seeded on a 6-well plate in 1 ml of media. The cells were treated with
supernatants collected after centrifuging 100 µg/ml gardi-mPDA nanoparticles at 8000 rpm for
10 minutes. For gardi-mPDA-NIR, the particles were treated with 10 minutes of 808 nm laser
(14mW/mm2) right before centrifugation. The collected supernatants were added to BMDCs and
incubated for 24 hours. The cells were harvested using a cell scraper and centrifuged at 1000 rpm
for 5 minutes. The supernatant was used for assessment of cytokine (IL-6 and TNFα) levels
using ELISA (R&D Systems, Minneapolis, USA). The cells were fixed using 10% neutral
buffered formalin (NBF) for 20 minutes at room temperature and then washed with PBS. The
cells were then blocked using CD16/CD32 (Mouse BD Fc Block™) and stained for APC-CD40
and PE-CD80 followed by analysis using flow cytometry (Acea Novocyte, San Diego, USA).
Uptake of nanoparticles
For studying the uptake of the nanoparticles, BMDCs were treated with 100 µg/ml of LT680mPDA. After incubating for 1 hour, the cells were washed and fixed with 10% NBF (20 minutes)
followed by washing three times with PBS. NIR laser was treated for 2 minutes to release some
dye and prevent the LT680 self-quenching. The cells were then stained with DAPI using
manufacturer’s protocol. The images were acquired using Zeiss LSM 880 Confocal fluorescence
microscope.
In vitro combined photothermal and immune-stimulation study
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For probing the combined photothermal and immune-stimulation efficacy of nanoparticles,
1×106 B16-F10 cells per well were seeded in a 6 well plate followed by incubation with either
LT680-mPDA or gardi-mPDA nanoparticles (100 µg/ml). After incubating with the
nanoparticles for 1 hour, cells were harvested and washed three times with PBS (1100 rpm, 5
minutes). The cells were then stained with 1 µl of CellTrace™ CFSE (Invitrogen™, Carlsbad,
USA) for 20 minutes at room temperature. The cells were then washed with complete media and
divided into two groups of 2x106 cells in 100 µl of culture medium. The first group was
subjected to 10 minutes of 808 nm laser (14 mW/mm2) treatment, followed by dilution of cells in
1 ml of culture medium. The second group was directly diluted in 1 ml of medium and the cells
from both the groups were seeded in a 6-well plate for incubation at 37oC for 12 hours. Cells
from both the groups were harvested and centrifuged at 1100 rpm for 5 minutes. The LICOR
Odyssey CLx scanner was used to measure the fluorescence intensity of the LT680 and
fluorescence plate reader (Molecular devices, SpectraMax ID3) was used to measure the
fluorescence intensity of CFSE in the supernatant. For immune-stimulation study B16-F10 cells
were treated with gardi-mPDA instead of LT680-mPDA as described above. The supernatants
collected from the two groups were treated on BMDCs (1x106) seeded in a 6-well plate.
Supernatant from BMDCs was collected 24 hours post-treatment and the IL-6 secretion was
measured using ELISA (R&D Systems, Minneapolis, USA).
In vivo photothermal efficacy and drug release
Photothermal treatment was performed 1-day post-injection of PDA@mSiO2 nanoparticles into
the tumor site. Mouse injected with gardi-mPDA was anaesthetized and subjected to 808 nm
laser (power density of 14 mW/mm2 and laser spot size of 5 mm). The body hair was removed
from the tumor site to eliminate the external factors affecting the photothermal heating. The
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tumor injected with gardi-mPDA nanoparticles was irradiated with laser for 5 minutes. The
corresponding tumor surface temperature was measured using an IR camera. Identical NIR
irradiation was performed on a tumor-inoculated mouse without particle injection to collect the
tumor surface temperature during treatment, as a control.
For drug release experiment, 7 days after B16-F10 tumor inoculation, mice were scanned using
LICOR scanner for background fluorescence. Then 10 µl of LT680-mPDA were adminstered
intratumorally, followed by fluorescence imaging one immediately and the other 10 minutes
after adminstration. The mice were then subjected to 14 mW/mm2 808 nm laser treatment for 5
minutes and then imaged. Fluorescence intensity (FI) after particle injection was considered as a
reference and the fold increase was calculated for 10 minutes without NIR and with NIR.
In vivo tumor model
Six to eight weeks old C57Bl/6 mice were inoculated on the right flank with 1x106 B16-F10 cells
(s.c) in 100 µl of HBSS. On day 6, mice bearing tumor with a diameter of 4-6 mm were selected,
numbered and divided into 4 groups (n=7). The mice in different groups were administered 50 µl
of PBS, gardi-mPDA, PDA@mSiO2 and gardi-mPDA intra-tumorally. 24 hours after injection,
PDA@mSiO2 and one gardi-mPDA group was treated with 808 nm laser (14 mW/mm2) for 5
minutes. 24 hours allows diffusion within the tumor and uptake of injected nanoparticles by the
cancer cells. The body weight and tumor diameters were measured every other day till day 19
after tumor implantation using a sliding caliper. Tumor volume was calculated as following:
tumor volume = length × (width)2/2. For survival study, the treated animals were observed for at
least 42 days. For secondary tumor challenge, tumor-free mice at day 28 were re-challenged with
5x105 B16-F10 cells on the opposite flank. For histopathological analysis, the heart, kidney,
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liver, spleen and lungs were harvested 2 weeks after immunization and processed for
hematoxylin−eosin staining.
In vivo flow cytometry analysis
To assess the population of immune cells in tumor draining lymph nodes, the inguinal lymph
node from the tumor bearing side was isolated and digested using 0.5 mg/ml collagenase I and
0.1 mg/ml DNAase in DMEM at 37oC for 1 hour. Nylon mesh filter (70 µm) was used to prepare
single cell suspension followed by washing three times with PBS. The cells were subjected to
blocking using CD16/CD32 (Mouse BD Fc Block™), followed by staining with FITC-CD11c,
PE-Dazzle-CD3, FITC-CD8, APC-CD40, PE-CD80 and Per CP-MHC II (eBiosciences, San
Diego, USA ) for 1 hour at room temperature in dark. The cells were washed three times with
PBS and then analyzed using flow cytometry (Acea Novocyte, San Diego, USA).
Statistical analysis
For analyzing the statistical difference between two groups, unpaired two-tailed t-test with
Welch's correction was used. For analyzing the statistical difference between more than two
groups, one-way ANOVA with post-hoc Tukey’s honest significance test was used. Statistical
significance of the data was calculated at 95% (p < 0.05) CIs.

For analyzing statistical

significance in survival data log-rank (ManteleCox) test was used. All values are expressed as
mean ± standard deviation from three or more independent or repeated experiments. GraphPad
Prism 6 (San Diego, CA, USA) was used for all statistical analysis and Origin and GraphPad was
used for creating all figures.
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4.5 Supporting Information
Supporting Information for chapter 4 is provided in appendix 3.
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4.6 Figures

Figure 4. 1 Schematic illustrations depicting (A) Synthesis of gardiquimod-loaded mesoporous
silica coated polydopamine nanoparticles (gardi-mPDA) and NIR-assisted drug release. (B)
Tumor ablation and drug release under NIR irradiation followed by activation of DCs and
effector T cells in tumor draining lymph nodes for regression of primary and secondary tumors.
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Figure 4. 2 TEM images of the (A) PDA and (B) PDA@mSiO2 nanoparticles. (C) hydrodynamic
diameter and (D) zeta potential of the PDA and PDA@mSiO2 nanoparticles. SEM images of the
(E) PDA and (F) PDA@mSiO2 nanoparticles. (G) Pore size distribution of PDA@mSiO2
nanoparticles obtained by nitrogen adsorption and using Barrett-Joyner-Halenda (BJH) method.
(H) Weight loss profiles of PDA and PDA@mSiO2 nanoparticles as measured by
thermogravimetric analysis.
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Figure 4. 3 (A) Schematic representation of NIR irradiation of pristine PDA@mSiO2
nanoparticles and IR images of temperature rise with increase in particle concentration after 5
minutes of NIR laser treatment. (B) Temperature profile and effect of PDA@mSiO2 particle
concentration on temperature rise when aqueous solutions were subjected to laser power density
of 14 mW/mm2. (C) Cumulative release of model dye from the PDA@mSiO2 nanoparticles after
different laser irradiation durations and their corresponding solution temperature (laser power
density, 14 mW/mm2). (D) Schematic representation of gardiquimod loaded PDA@mSiO2
(gardi-mPDA) nanoparticles and release of cargo with NIR treatment. (E) Cancer cell viability
after treatment with gardi-mPDA with and without NIR. BMDC activation indicated by cytokine
secretion (F) IL-6 and (G) TNFα. Data represented as mean ± SD. ** p<0.01, *** p<0.001 and
**** p<0.0001 by one-way ANOVA with Tukey’s posttest.
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Figure 4. 4 Combined photothermal-immunotherapy effect in the presence of NIR. (A)
Schematic illustration describing the experiment. Briefly, B16-F10 cells were treated with
LT680-mPDA followed by labelling with CFSE. The labelled cells were divided into 2 groups
and one group was given NIR treatment for 10 min. The supernatant of 2 groups were collected
after 12 hours and fluorescence intensity was measured. (B) Fluorescence images (LT680) of
supernatants collected from cells treatment with and without NIR, (C) Fluorescence intensity of
CFSE and LT680 with and without NIR, (D) IL-6 secretion by BMDCs treated with supernatants
released from B16-F10 cells. Data represented as mean ± SD. * p<0.05 and **** p<0.0001 by
one-way ANOVA with Tukey’s posttest.
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Figure 4. 5 In vivo photothermal-immunotherapeutic effect of gardi-mPDA.(A) Timeline of
experiment. (B) In vivo toxicity of gardi-mPDA and NIR assessed by change in body weight of
the mice, (C) tumor growth profiles, (D) survival curve of mice given different treatments (n=7).
Tumor growth curves of individual mouse after treatment with (E) PBS, (F) PDA@mSiO2-NIR,
(G) gardi-mPDA and (H) gardi-mPDA-NIR. (I) Tumor volume after secondary challenge in
mice surviving after gardi-mPDA-NIR treatment (vaccinated mice) and age matched naïve mice
(n=3). (J) Hematoxylin−eosin (H&E) staining images of major mice organs after treatment with
PBS and gardi-mPDA-NIR. Data represented as mean ± SD. * p<0.05 and **** p<0.0001 by
one-way ANOVA with Tukey’s posttest and Log-rank (Mantel-Cox) test for survival curve.
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Figure 4. 6 Relative populations and activation status of immune cells in tumor draining lymph
node at day 16. Representative flow cytometry plots of (A) CD3+ CD8+ T cells, (B) CD11c+
CD80+ dendritic cells. Percentage positive cells are displayed on top right corner.
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Chapter 5: Reversible Photothermal Modulation of
Electrical Activity of Excitable Cells using
Polydopamine Nanoparticles
5.1 Introduction
Controlling a selective population of neurons to understand and establish a causal link between
the neural activity and overall behavioral outcomes is a grand challenge in systems neuroscience.
Harnessing the unique properties of matter at the nanoscale to tackle this grand challenge has
received increased attention over the past few years.204-208 Among the many methods that aim to
modulate the biological processes, a particularly attractive method is photo-regulation, a process
in which light is utilized as an external stimulus 67. Since cells by themselves are not sensitive to
photo-stimulation, insertion of light-sensitive ion channels and subsequent stimulation of these
neurons for selective control (i.e. optogenetics), has become an increasingly popular and staple
tool for numerous investigations.68-69 While optogenetic techniques are promising and have
revolutionized basic research aimed at understanding the computational and behavioral role of
several different neural populations, there are still several limitations associated with these
techniques that remain to be addressed.70-72 These include: (i) ability to excite neurons that are
embedded deep in the tissue; (ii) ability to be widely used in different model organisms with or
without a rich repertoire of genetic tools; (iii) graded control of neurons; (iv) ability to control
different subset of neurons in a concurrent fashion; (v) reversibility of the proposed approaches
to return the controlled neurons to their original configuration; and more importantly (vi)
feasibility of developing a non-invasive approach. To address some of these shortcomings, the
use of nanomaterials for non-genetic electrical and thermal stimulation were explored and tested
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successfully in recent years.73 Among these, photothermal methods have shown great promise
and versatility in stimulating neuronal cells 74-82.
It has been reported that the absorption of the infrared (IR) light by water, converting it to
thermal energy reversibly alters the electrical capacitance209 and therefore the excitability of
nerve cells. However, direct IR stimulation is a non-specific approach that excites (or inhibits)
many neurons in the area where optical illumination targets. The use of thermal energy as a
stimulus to activate neurons could be highly localized to avoid generic effects on neuronal firing
and their behavior. Plasmonic nanostructures such as gold nanorods (AuNRs), which serve as
locoregional photothermal transducers, have been employed to modulate (inhibit/stimulate)
neural activity in vitro using NIR light74,

76, 81-82, 210

. Radio-frequency magnetic-field based

heating of magnetic nanoparticles has also been demonstrated to be effective in thermal
activation of ion channels and triggering action potentials in cultured neurons211-212. Magnetic
nanoparticles were also used to target the motor cortex of moving mice and modulate its
movement through magnetothermal stimulation78.

Among various nanomaterials that could

transform light energy to heat, polydopamine (PDA) nanoparticles are a particularly promising
candidate for neuronal modulation due to their excellent photothermal properties,
biocompatibility,

biodegradability,

and

facile

surface

functionalization54.

PDA-based

nanomaterials have been widely investigated as photothermal agents for photothermal cancer
therapy.55-57 Furthermore, due to their biocompatibility and superior interaction with cells, PDAbased nanomaterials have been shown to be promising candidates for neuronal interfacing 58-60.
Here, we explore the use of biocompatible and biodegradable polydopamine nanoparticles and a
novel highly porous biofoam as photothermal agents to stimulate excitable cells such as neurons
and cardiomyocytes with NIR light in a non-disruptive manner. This novel nanomaterial
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approach was utilized to localize the temperature around the excitable cells under 808 nm laser
illumination. The change in the activity of neurons was monitored and quantified to understand
the effect of different photothermal heating conditions. Electrical activity was measured for
neurons and cardiomyocytes cultured on microelectrode array (MEA) to assess the ability of
PDA nanoparticles and PDA-based foam to modulate the cell excitability. Series of quantitative
analyses were performed to explain the effect of laser light intensity in the presence of PDA
nanoparticles in modular and reversible control of the neuron and cardiomyocyte activity.

5.2 Results and Discussion
PDA nanoparticles are synthesized by oxidative self-polymerization of dopamine monomer in
water–ethanol–ammonium mixture at room temperature, using a previously reported method

213

.

Scanning electron microscopy (SEM) image and dynamic light scattering (DLS) measurement
revealed the diameter of the PDA particles to be ∼465 nm (Figure 5.1B and 5.1C). It has been
recently reported that nanoparticle’s interaction with neurons is solely dependent on its surface
charge regardless of the shape, size and composition

214

. Negatively charged particles tend to

adhere to the neuron cell membrane more efficiently than other particles. Polydopamine, due to
the presence of hydroxyl and amine functional groups on its surface, exhibits different surface
charge under different pH conditions, with an isoelectric point at 3.3

130

. Under physiological

conditions (pH=7.4), the zeta potential of PDA was measured to be -30.6 ± 0.3 mV (Figure
S5.1). PDA particles exhibited broad optical absorption ranging from 400 nm to 800 nm with a
peak around 500 nm (Figure 5.1D). Polydopamine nanoparticles exhibit excellent
biocompatibility and biodegradability and provide high photothermal conversion efficiency and
have been used as contrast agents for photothermal therapy

55

. Under 808 nm laser irradiation

(power density of 14 mW mm-2), PDA particle solution temperature increased with an increase
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in the concentration of the nanoparticles. For a concentration of 400 µg ml-1, the temperature
increased by 30 ºC within 4 minutes, although the cell experiments are not conducted for this
long period to prevent cell death (Figure 5.1E). It is worth noting that smaller changes in
temperature ( 5 ºC) as would be desirable for controlling cell excitability can be achieved
within a few seconds. The magnitude of temperature rise under NIR laser irradiation can be
controlled by tuning the power density of the laser, which is critical to avoid photothermallyinduced cell death (Figure 5.1F and 5.1G). Considering that the light absorption of cells and soft
tissues in the NIR range is significantly lower compared to that in the visible part of the
electromagnetic spectrum, 808 nm laser employed here confines the heat to the proximity of the
photothermal nanoparticles, thus enabling locoregional neuromodulation 215-216.
To study the effect of nanoheating on the neuron viability, primary hippocampal neurons from
prenatal rat were cultured on a substrate pre-coated with polyethylenimine (PEI) and laminin,
sequentially. After 14 days in vitro, the neurons were immunolabeled for β-tubulin (III), which
indicates good adhesion of neuron cells to the substrate and its long-term viability (Figure 5.2A)
76

. The effect of photothermal heating on the viability of cultured neurons was examined by

incubating them with PDA NPs and applying NIR light (Figure 5.2B). When irradiated with 808
nm laser at a power density of 14 mW mm-2 in the presence of PDA NP for 1, 2 and 5 minutes,
no noticable change in the viability of the neurons compared to the control groups was observed.
The viability of neurons subjected to laser with and without PDA NP remained above 90%,
indicating that the photothermal stimulation can be employed to modulate neuronal activity
without inducing cell death.
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To investigate the effect of photothermal heating on neurons activity, hippocampal neurons were
cultured on microelectrode arrays (MEAs) and extracellular activity of neurons was recorded
with and without PDA treatment and NIR stimulation (Figure 5.2C). Neurons cultured on MEA
formed a dense network of neurites around TiN recording electrodes (Figure 5.2D). To ensure
that the activity of the cultured neurons is stable and does not change over time, extracellular
activity was recorded for 30 min without PDA treatment and NIR stimulation (Figure S5.2). The
overlaid waveform of cultured neurons exhibited stable activity without any significant change in
the spike shape or amplitude over the entire recording duration (Figure 5.2E). Before stimulating
the neurons with NIR laser in presence of PDA, the effect of PDA treatment on neurons baseline
activity was examined (Figure 5.2F). Upon adherence of PDA nanoparticles to the plasma
membrane of neurons, the mean spike rate of the neurons increased. This is possibly because the
negatively charged PDA NPs induce a depolarization of the membrane potential by providing
negative charge extracellularly to cause increased firing 214.
Following the formation of a complete network and reaching a stable spontaneous activity
(approximately 14 days in vitro (DIV)), the neurons cultured on the MEAs were treated with
PDA NPs (100 µg ml-1 final concentration) and incubated overnight. The PDA NPs adhered to
neurons and the substrate and the rest of them gradually settled down and created a bed of
particles on the cells and neurites which resulted in a particle-free solution before the activity
recording and photothermal stimulation. The PDA NP-treated neurons were subjected to
repeated irradiation of 808 nm laser at different power densities for different stimulation duration
(10, 20 and 30 seconds) in a back-to-back pulsatile fashion. The extracellular activity of the
neurons was recorded before, during, and after the photothermal treatment (Figure 5.3A).
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As can be noted, the neurons had spontaneous activity before any photo-stimulation. During the
NIR irradiation, the number of action potentials fired reduced below spontaneous activity levels.
Fewer spikes were detected for all power densities and for all durations tested (Figure 5.3A and
5.3B). The spike rate decreased monotonically with an increase in the NIR laser power density
from 3 to 6 mW.mm-2 (Figure 5.3C). At laser power density of 3 mW mm-2, there was only 39%
reduction in the spike rate compared to before NIR stimulation. The spike rate reduction reached
98% when laser power density increased to 6 mW.mm-2, suggesting an almost complete
shutdown of neuron activity under these irradiation conditions. In comparison, neuron activity
was recorded for cultures that were not treated with PDA NP but subjected to 808 nm laser
irradiation (Figure S5.3). The neuron activity did not change even under a significantly higher
laser power density of 14 mW mm-2 (Figure S5.3A). In the experiment without the presence of
PDA particles, the mean spike rate measured before and during the laser irradiation did not
change significantly. To investigate the effect of repeated laser stimulation, neuron activity was
recorded for cultures treated with PDA NP and over 10 repeats of 30-second NIR pulses at 6
mW mm-2 where almost complete activity shutdown was observed (Figure 5.3D, S5.4). The
similarity in neural spike activity observed, summarized as a correlation matrix, during different
photothermal stimulation periods/cycles/pulses showed that the evoked photothermal responses
were highly similar. Photothermal treatment had a culture wide and universal effect of in
inhibiting neuron activity (Figure S5.4A). The mean spike rate for PDA NP-treated neurons was
measured before the laser irradiation and after the finish of each cycle to reveal the possible
permanent effect of photothermal treatment on neuron activity (Figure 5.3E).

Although

complete shutdown of extracellular activity was noted during the laser irradiation (with PDA NP
and at 6 mW mm-2), the mean spike rate after laser irradiation remained virtually identical to that
92

observed

before

irradiation,

indicating

the

reversible

nature

of

the

photothermal

neuromodulation. Moreover, the spike shape and amplitude before and after the photothermal
treatment did not show significant change for the same experiment indicating that neurons
recovered their activity after photothermal treatment with no sign of temporary or permanent
damage (Figure S5.5).
Following the NIR irradiation period that resulted in complete inhibition of the neural activity,
we noted that the neurons do not start firing immediately after stopping the irradiation but
recovered their baseline activity after a short time lag. We investigated the dependence of the
neural activity recovery time on the laser power density and laser irradiation duration (Figure
5.4). By fixing the irradiation duration and increasing the laser power density from 3 to 6 mW
mm-2, the activity recovery time (the period between the end of NIR irradiation and the first
spike for each electrode) increased significantly for all of the laser durations tested (Figure
5.4A). There was a small increase in the recovery time with an increase in the laser power
density from 3 to 4 mW mm-2. An increase in the laser power density from 4 to 6 mW mm -2,
resulted in a much larger increase in the lag time (Figure 5.4C). This is possibly due to the long
cooling period required at higher laser power densities, where the maximum temperature under
laser irradiation is higher (Figure 5.1F). Alternately, stronger hyperpolarization during photostimulation period that at higher laser power densities could also result in longer recovery of
resting membrane potential which could underlie similar monotonic increase in recovery time
with response strength. In the case of fixed laser power density, an increase in the laser
irradiation duration resulted in a monotonic increase in the activity lag time (Figure 5.4B). This
increase in the activity lag time was more pronounced at the higher laser power density of 6 mW
mm-2 (Figure 5.4D). The particles on the substrate immediately adjacent to the neurons also
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contribute to the localized heating and delay the cooling process once the laser is turned off, thus
causing a significant lag in the neuron activity recovery after each photothermal stimulation
cycle. The tunable activity lag time with the laser power density and laser irradiation duration
serves as an additional handle in light-based neuromodulation. On the other hand, specific
targeting of the photothermal nanostructures to the neurons can minimize the non-specific
adsorption of the nanostructures on the substrate and possibly minimize the activity lag time.
To test the generality of photothermal modulation on controlling cellular excitability, we have
investigated the effect of PDA NPs and laser treatment on the electrical activity of
cardiomyocytes. The iPSC-derived cardiomyocytes were differentiated and plated on the MEAs
to assess the beating rates of cardiac tissues (Figure 5.5A). Without PDA NPs, upon laser
stimulation, the beating rates of cardiac tissues increased only slightly (less than 10%) and
recovered to baseline rate once the laser irradiation is stopped (Figure 5.5B and 5.5C). Following
the incubation of cardiomyocytes with PDA nanoparticles for 24 hours, the beating rates under
laser irradiation increased significantly compared to untreated cells subjected to laser irradiation
(Figure 5.5D and 5.5E and supporting information Figure S5.6). These results indicate the
successful modulation of the electrical activity of the cardiomyocytes with photothermal
nanostructures. To further understand the effect of localized heating on the tissue, PDA NPtreated tissues were subjected to different laser power densities from 4 to 25 mW mm -2 (Figure
5.5F-H and supporting information Figure S5.7). With an increase in the laser power density
from 4 to 14 mW mm-2, the beating rate progressively increased and reached to about 1.8 times
of the baseline activity (Figure 5.5F). For the highest laser power density (25 mW mm-2), the
cardiomyocytes exhibited irreversible changes in the beating rate, indicating possible thermal
toxicity (Figure S5.7). The tissues not treated with PDA NPs exhibited only a small increase in
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the beating rate with a maximum increase of less than 10% at 14 mW.mm-2. These results
demonstrate that the iPS-derived cardiac tissues showed a significant response to the localized
nano-heating in the presence of PDA NPs with NIR laser irradiation. Also, the nature of the
response changed from excitatory at lower laser power densities to inhibitory at laser power
densities above 14 mW mm-2 (Figure 5.5 and S5.7). The tunable modulation of the electrical
activity of cardiomyocytes using PDA NPs could be harnessed for excitation and inhibition of
cardiac activity is desired, simply by changing the laser power density.
The results discussed so far involve the incubation of the neurons (or cardiomyocytes) with
colloidal PDA NP, which offers poor control over the distribution of the photothermally-active
nanostructures.

To achieve better spatial control over photothermal stimulation and better

photothermal performance, we have designed a highly porous 3D collagen foam modified with
PDA NPs as a conformal photothermal substrate (Figure 5.6A). Collagen foam is widely used in
biomedical applications (e.g., wound dressing, tissue culture scaffolds) due to its highly porous
structure and excellent biocompatibility.217-218 Pristine collagen foam is white (due to light
scattering) and does not possess photothermal activity (Figure S5.8A). When the collagen foam
is exposed to a high concentration solution of PDA nanoparticles, within a few minutes, the
collagen fibers are completely covered with PDA nanoparticles, as is indicated by its change of
color from white to black (Figure S5.8B). SEM images of the PDA-modified collagen foam
(PDA/Collagen) reveal the high porosity and the PDA nanoparticles adsorbed on individual
collagen fibers (Figure 5.6B). The PDA/collagen foam was found to be highly stable with no
noticeable desorption of the PDA NP even under mechanical agitation. The absorbance spectrum
of the PDA/collagen foam is similar to that of PDA NP solution suggesting that photothermal
efficiency for the foam should be similar to the PDA NPs (Figure 5.6C). In its dry state, the
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surface temperature of PDA/collagen foam increased by more than 100 ºC in just less than 10
seconds when irradiated by laser at a power density of 6 mW mm-2 (Figure S5.9). Even at a
much lower laser power density of 3 mW.mm-2, we noted a 60 ºC increase in the local surface
temperature within the first 10 seconds. In wet state, the foam surface temperature rose by up to
12 ºC after 10 seconds and by up to 20 ºC after 30 seconds of irradiation at a laser power density
of 6 mW mm-2 (Figure 5.6D). The superior photothermal activity of the PDA/collagen foam
compared to the high concentration of PDA NPs (100 µg ml-1) stems from the highly dense
adsorption of the PDA NPs on the collagen fibers and efficient light trapping within the foam
due multiple reflections. In addition to the excellent photothermal properties, the highly porous
PDA/collagen foam soaked in the cell culture medium can be applied as a conformal patch on
cells and tissues.
To investigate the efficacy of PDA/collagen foam in photothermally modulating the neural
activity, the foam was placed on the neurons cultured on the MEAs for 14 DIV, and after the
neurons reached stable spontaneous activity.

The neurons with PDA/collagen foam were

subjected to repeated irradiation of 808 nm laser at different power densities for different
stimulation durations (10, 20 and 30 seconds). The extracellular activity of the neurons was
recorded during the photothermal treatment and it is evident that spiking activity during the
photothermal stimulation is reduced drastically (Figure 5.6E and 5.6F). The quantitative
measurement of the changes in the spike rate showed that at all the power densities tested, the
neuron activity suppression was above 90% (Figure 5.6G). In comparison, at the same power
density of 3 mW mm-2, photothermal treatment of neurons treated with colloidal PDA NP
resulted in only a 39% reduction in neuron activity. Moreover, when the power density was
increased to 15 mW.mm-2, PDA/collagen foam resulted in permanent damage to cells, and the
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activity suppression was not reversible. This superior photothermal performance of the
PDA/collagen compared to colloidal PDA NP allows the utilization of lower power light sources
(e.g. near-infrared LEDs) instead of laser for modulating the neural activity. Furthermore, this
PDA/collagen 3D foam could be easily applied as a patch on brain tissues and cardiac tissues for
modulating the electrical activity in a facile manner.

5.3 Conclusion
In conclusion, we have demonstrated the reversible and graded control of the electrical activity
of excitable cells using PDA nanoparticles as biocompatible and biodegradable photothermal
transducers. In the presence of PDA nanoparticles, the spike rate of neurons was significantly
suppressed under NIR laser irradiation with a power density as low as 3 mW mm-2. With a
progressive increase in the laser power density, we observed a monotonic decrease in the spike
rate. The activity recovery time was found to be dependent on irradiation power density and
irradiation duration. The neural activity suppression and recovery were repeatable over 10
consecutive pulses of laser irradiation in a single trial, demonstrating the robustness of this noninvasive neuromodulation approach. In the presence of PDA nanoparticles, the beating rate of
cardiomyocyte tissues progressively increased as the irradiation laser power density increased
from 4 to 14 mW mm-2. To improve the ease of interfacing the photothermal agents with neural
cultures and brain tissues, we have designed and realized a 3D collagen/polydopamine
nanoparticle foam and applied it on the cultured neurons as an “add-on” patch. The 3D foam
demonstrated superior photothermal and neuromodulation performance compared to colloidal
polydopamine nanoparticles in that we observed more than 90 percent reduction in neuron
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activity even at laser power densities as low as 3 mW mm-2.

Compared to inorganic

photothermal nanostructures (e.g., noble metal nanoparticles), PDA nanostructures are better
suited for in vivo neuromodulation owing to their high biocompatibility and biodegradability.
We believe that this novel material platform for non-invasive neuromodulation can be easily
extended to other excitable cells both ex vivo and in vivo and serve as a valuable tool in nanoneuroengineering.

5.4 Experimental Section
Cell Culture: All procedures have been approved by the Institutional Animal Care and Use
Committee (IACUC) at Washington University in St. Louis. Hippocampal tissues were dissected
from embryonic day 18 Sprague_Dawley rat brain (Charles River, USA). The tissues were
transferred into Hibernate EB medium (HEB, BrainBits, USA) for further use. Cell dissociation
solution was prepared by dissolving 6 mg papain (P4762, Sigma, USA) in 3 ml of Hibernate ECa (HE-Ca, BrainBits, USA). Hippocampal tissues were transferred to the cell dissociation
solution and incubated at 30 ºC for 10 minutes. Dissociation solution was removed and HEB
medium was added to the tissues, followed by trituration with fire-polished Pasteur pipette. Cell
dispersion was centrifuged (200×g, 1 minute) and supernatant was removed, and pellets were
resuspended

in

NbActiv4

(BrainBits,

USA).

Substrates

were

pre-treated

with

poly(ethyleneimine) solution (0.1 % in water, P3143, Sigma, USA) for 30 minutes followed by
air drying. Before the cell seeding, substrates were treated with laminin solution (20 µg ml -1 in
NbActiv4 medium, L2020, Sigma, USA). After removing the extra laminin solution, cells were
seeded at the density of 500-1000 cells.mm-2 and maintained in the NbActiv4 medium in a
humidified incubator with 5% CO2 and 37 ºC condition. After 2 days, half of the medium was
changed with fresh NbActiv4 medium and was regularly changed every 4 days.
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For iPS-derived cardiomyocytes (iPS-CMs), the WTC-11-GCaMP6 from Bruce Conklin Lab in
Gladstone Institute were used as the induced pluripotent stem cells (iPSC). The iPSCs were
maintained in E8 medium (Thermo Fisher Scientific) on Matrigel-coated (Corning) tissue culture
plate and passaged every four days. The protocols used to differentiate and purify iPS-derived
cardiomyocytes (iPS-CMs) was through Wnt modulation and lactate purification that was
previously described 219-220.
Polydopamine Nanoparticle and Collagen/Polydopamine Foam Preparation: All chemicals
were purchased from Millipore Sigma, St. Louis, USA and used without further modification.
Polydopamine particles were synthesized by using a method described elsewhere.213 In a typical
synthesis procedure of polydopamine nanoparticles, 252 mL of deionized (DI) water (resistivity
>18.2 MΩ·cm) was mixed with 112 mL of ethanol in a 1000 mL glass container. Subsequently,
1.96 mL of aqueous solution of ammonia (28−30% NH4OH) was introduced into the above
water/ethanol mixture. After stirring for 30 min, the aqueous solution of dopamine hydrochloride
(1.4 g in 28 mL) was added to the above solution. The reaction was left under gentle magnetic
stirring for 24 h with no cap on the glass container. The PDA particles were collected by
centrifugation (9000 rpm, 10 min) and washed with DI water three times and dispersed in water
(320 mL).
To prepare the photothermally active 3D foam, a collagen film (HeliTAPE Collagen Wound
Dressing, Miltex® Instruments, USA) was soaked in water to create a hydrogel. The collagen
hydrogel wass then freeze-dried to achieve a highly porous 3D foam. The collagen foam, was
soaked in the PDA NP solution (1 mg ml-1 in water) and left for 5 minutes with shaking followed
by washing with water to remove the excess nanoparticles. The PDA NP-loaded collagen foam
was freeze-dried again to be used in the photothermal stimulation experiments.
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Material Characterization: Scanning electron microscopy (SEM) images were obtained by using
a JEOL JSM-7001 LVF Field Emission scanning electron microscope. Dynamic light scattering
(DLS) and zeta potential measurements were performed using Malvern Zetasizer (Nano ZS).
Shimadzu UV-1800 spectrophotometer was employed for light absorption measurements.
Photothermal Stimulation: A fiber optic NIR laser (808 nm) was used for a light source and the
laser beam spot size and power density was controlled by its distance from the microelectrode
array (MEA, Multichannel Systems, Germany). Hippocampal neuronal networks were cultured
on a MEA chip and incubated with PDA NPs overnight. The PDA NP-treated neurons were then
repeatedly irradiated with a NIR laser (808 nm) at different power densities and durations. A
typical photothermal experiment lasts for 330 seconds, and the cells were illuminated with laser
at different power densities for 10, 20 and 30 seconds. The laser on and off was controlled by a
mechanical shutter. For repeatability experiment, cells were illuminated for 30 seconds with a
power density of 6 mW mm-2 followed by 90 seconds of no laser illumination for 10 cycles. The
experiment for calculating the neuron activity recovery time after laser illumination was
performed by recording the activity for 60 seconds followed by laser pulses with different
durations and power densities followed by at least 90 seconds wait time, for a total of 210
seconds. Same experimental procedures were followed for cardiomyocytes.
Electrical Activity Recording: Neural recordings were obtained from neuronal cultures at the age
of 14-18 DIV. Extracellular activity from cultured neurons were monitored using 60-channel
TiN microelectrode arrays (MultiChannel Systems, diameter 30 μm, electrode spacing 200 μm,
500 nm thickness of Si3N4 insulator). Electrode signals were amplified and digitized with an in
vitro MEA system (Multichannel systems, gain 1100, bandwidth 10-8 kHz, sampling frequency
25 kHz). The recorded signals were filtered with a 200 Hz digital high pass filter (Butterworth,
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second order), and spikes were detected by setting the threshold level at five times the standard
deviation of background noise using vendor provided software (MC Rack, MultiChannel
Systems). Recording condition was maintained at 37 ºC and 5% CO2. Collected data were
processed using MATLAB (MathWorks). For bulk heating experiments, the head stage
temperature was adjusted to desired value and after 15 minutes of stabilization, the neuron
activity recording was performed. To test the effect of PDA NP on neuron activity without laser
stimulation, the extracellular activity of cultured neurons was recorded for 30 minutes before
addition of PDA NP after which the culture was incubated with PDA NP solution (100 µg ml-1
final concentration).
To record the field potential activities of iPS-CM, the iPS-CMs were suspended at 30 × 106 cells
ml-1 and a 4 µl droplet was seeded on the recording area of MEA probe (60MEA200/10iR-Ti).
The field potentials were recorded using MC_Rack software (Multichannel Systems) at 10000
Hz sampling rate with a 200 Hz digital high pass filter (Butterworth, second order). The data
were converted to ABF format using MC_Data Tool (Multichannel Systems) and the field
potentials were analyzed using Clampfit 10.7 (Molecular Devices) and MATLAB (MathWorks).
Cell Viability: Hippocampal neurons were cultured in pre-treated 96 well black plates at the
density of 20000 cells per well for 14 DIV and treated with PDA NPs at 100 µg ml-1 final
concentration. After 5 h incubation, they were subjected to 808 nm laser for 10 minutes at a
power density of 14 mW mm-2. After 24 hours, MTS assay was performed as per manufacturer
protocol.
Data Analysis: Recording channels whose average firing rate was larger than 0.1 spikes per
second were selected as active channels and used for neural activity analysis. For the analysis of
spontaneous activity, peri-event time histogram and raster plots were used with the NIR
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irradiation as an event. The spike rate reduction (ΔR/R) with or without the NIR irradiation was
calculated by the following equation: ΔR/R (%) = [R(ON) - R(OFF)]/ R(OFF), where R(OFF)
and R(ON) indicated the average spike rate before and after the onset of NIR irradiation,
respectively. R(ON) covered the entire irradiation period (5-45 seconds), and R(OFF) covered
the 30 second window just before the onset of the irradiation. All statistics were performed with
5% significance level.
Immunostaining: Hippocampal neurons were fixed in 4% neutral buffered formalin in 1x PBS
for 30 minutes at room temperature and washed with PBS three times. To permeabilize the cells,
neurons were incubated with 0.5% Triton X-100 in 1x PBS for 10 minutes at room temperature
and washed with PBS three times. The nonspecific binding of antibodies was blocked by 6%
bovine serum albumin (BSA, Sigma) in PBS for 30 minutes, and washed with PBS once. The
biotinylated primary antibody (neuron-specific β-III tubulin antibody, 6 µg ml-1 in 1.5% BSA,
R&D systems MAB 1195) was added to the cells and incubated for 3 h at RT. After washing
with PBS for three times, streptavidin-tagged fluorescent dye (IRDye 800CW Streptavidin, 50 ng
ml-1 in 1.5% BSA, LI-COR) were incubated with the cells for 30 minutes at RT. After washing
with PBS for three times, DAPI solution (300 nM in PBS, Sigma) was used for nucleus staining.
Fluorescence images were obtained using Lionheart FX Automated Microscope (BioTek, USA).
The iPSC-derived cardiomyocytes were seeded on glass slide at Day 30. The cells were fixed
with 4% (v/v) paraformaldehyde for one hour and stained with primary antibody TNNT2
(ab45923; Abcam) and secondary antibody Alexa Fluor 488 goat anti-rabbit IgG (A11008;
Invitrogen) and nuclei counterstained by DAPI solution (1 µg mL-1).
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5.5 Supporting Information
Supporting Information for chapter 5 is provided in appendix 4.
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5.6 Figures

Figure 5. 1 (A) Schematic of Polydopamine nanoparticle (PDA NP)-mediated photothermal
stimulation of neurons. PDA nanoparticles localized on the neuron membrane, modulates the
neural activity through photothermal conversion of NIR light. (B) SEM image, (C) DLS
measurement and (D) Absorption spectra of PDA NPs. (E) Temperature changes in PDA NP
solution with different concentrations at 14 mW mm-2 laser power density. (F) Temperature
changes in 200 µg ml-1 solution of PDA NP at different laser power density and (G)
Corresponding IR Camera images of the PDA NP solution at the end of the laser illumination
period.
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Figure 5. 2 (A) Fluorescence images of cultured hippocampal neurons after immunochemical
staining with β-tubulin (III) (magenta) and nucleus (blue). (B) Cell viability of neurons subjected
to 1, 2 and 5 minutes of NIR irradiation (14 mW mm-2) without PDA NP (control) and with PDA
NP (100 µg ml-1 final concentration). The heat generated by NIR laser in presence of PDA NP
did not change the viability of the neurons compared to control sample (no PDA NP), meaning
that it is safe to use PDA NP for photothermal treatment of neurons. (C) Schematic of the
experimental setup with neurons cultured on a microelectrode array (MEA) and stimulated with
NIR laser with and without PDA NP treatment. (D) Phase contrast image of the hippocampal
neurons cultured on PEI-laminin coated MEA with cell density of 1000 cells mm-2. (E) Overlaid
waveform of hippocampal neurons at half an hour time interval. Neurons were not treated with
PDA NP and are not subject to any external stimulation. Spikes from 3-minute recording with
256 spikes in each set (no change in mean spike rate). Black curve shows the mean value for
each set. (F) Effect of localization of PDA NP on neuron membrane on the mean spike rate of
cultured neurons without NIR stimulation. Unpaired Two-samples t-test; p= 0.0018, n=56, *
p<0.05, ** p<0.01, *** p<0.001 and **** p<0.0001.
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Figure 5. 3 (A) Spike rates of neurons treated with PDA NP (100 µg ml-1) with NIR irradiation at
different power densities. (B) A single trace of spike recording for different NIR irradiation
periods (10 s, 20 s and 30 s laser irradiation at power density of 6 mW mm-2). (C) Quantification
of spike rate changes in panel A (effect of laser power density on spike rate change and
inhibition of neuron activity). (D) Spike rates of neurons treated with PDA NP (100 µg ml-1)
with NIR irradiation (power density of 6 mW mm-2) over 10 cycles of 30 s treatment. (E) Mean
spike rates of PDA NP-treated neurons before and after NIR irradiation ( Data were collected for
laser power density of 6 mW mm-2 where neuron activities were completely suppressed during
NIR irradiation, Unpaired Two-samples t-test; p= 0.8866, n=55).
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Figure 5. 4 (A) A single trace of spike recording for neuron treated with PDA NP at different
laser power densities for 20 s. Red lines show the activity lag time which is the amount of time it
took after the laser illumination for the first spike to appear. (B) Effect of laser duration on the
activity lag time for PDA NP treated neurons (power density of 6 mW mm-2). (C) Quantification
of the effect of the laser duration on the activity lag time at different laser power densities. (D)
Quantification of the effect of the laser power density on the activity lag time at different laser
duration times.
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Figure 5. 5 (A) The immunofluorescence images of iPSC-derived cardiomyocyte counter stained
with DAPI (blue) and cardiac troponin T (green). PDA nano-particles increased the beating rates
of iPS-derived cardiomyocytes. (B) The original trace of filed potential recording of iPS-derived
cardiomyocytes from MEA system without PDA treatment. The laser power density was 14
mW.mm-2 and was turned on for 10 seconds as indicated. (C) The representative traces of field
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potential recordings of iPS-CMs without treating with PDA nanoparticles before (black) and
after (red) 808 nm laser excitation. (D) The original trace of filed potential recording of iPSderived cardiomyocytes from MEA system. The iPS-CMs were treated with PDA nanoparticles
for 24 hrs and washed out before recording. The laser power density was 14 mW mm-2 and was
turned on for 10 seconds as indicated. (E) The representative traces of field potential recordings
of iPS-CMs treated with PDA nanoparticles before (black) and after (red) 808 nm laser
excitation. (F) – (H) The normalized beating rates of iPS-CMs before and after 808 nm laser
excitation. At different laser power densities (14, 6 and 4 mW mm-2), the laser was turned on for
10, 20 and 30 seconds at the indicated time. The beating rates were determined by calculating the
peak intervals of field potential recordings and normalized the rates at baseline.
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Figure 5. 6 (A) Schematic of experimental setup with neurons cultured on a microelectrode array
(MEA), Collagen foam + PDA NP placed on the culture and stimulated with NIR laser. (B) SEM
image (inset: higher magnification SEM) and (C) Absorption spectra of collagen foam + PDA
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NP. (D) Temperature changes of collagen foam + PDA NP in wet state at different laser power
densities. (E) Spike rates of neurons with collagen foam + PDA NP and NIR irradiation at
different power densities. (F) A single trace of spike recording for different NIR irradiation
periods (10 s, 20 s and 30 s laser irradiation at power density of 6 mW mm-2). (G) Quantification
of spike rate changes in panel E (effect of laser power density on spike rate change and inhibition
of neuron activity).
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Chapter 6: Conclusions
6.1 General Conclusions
Polydopamine-based organic nanomaterials possess excellent physical, chemical and optical
properties which make them promising candidates for environmental and biomedical
applications. They are rich with chemical groups on their surface that makes it easy to
functionalize them with many desirable chemistries and tune them for specific applications.
Polydopamine polymerization is a facile process which could be applied to almost any surface to
create favorable chemistry on surfaces that are normally hard to functionalize. The synthesis of
polydopamine nanoparticle is easy process and allows for creation of particles with different
shapes and sizes to be used in different applications. Polydopamine surface chemistry
demonstrates affinity to heavy metal ions and organic dyes, which make it excellent tool for
fabrication of multifunctional membranes and substrates for environmental applications. Also,
the excellent light-to-heat conversion efficiency of polydopamine nanomaterials enables it to
serve as biocompatible photothermally active nanomaterial for various biomedical applications.
This dissertation demonstrated several applications of polydopamine nanomaterials in
environmental and biomedical applications.
We have demonstrated a novel PDA/BNC composite adsorption membrane which has potential
to treat wastewater containing multiple inorganic and organic pollutants.

The PDA/BNC

membrane is fabricated by incorporating high density PDA particles inside BNC matrix during
its growth. This fabrication technique is highly versatile and can be easily adapted to incorporate
other adsorbents. All the materials used in the membrane fabrication process are biocompatible
and biodegradable. The unique fabrication process resulted in a highly uniform distribution of
PDA particles within the BNC matrix. The PDA/BNC membrane showed effective contaminant
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removal from feed water containing heavy metal ions and positively charged organic dyes at
high concentrations in a single pollutant or pollutant cocktail situations. The facile, inexpensive,
and scalable synthesis, excellent mechanical robustness and highly efficient removal of heavy
metals and organic dyes under complex conditions and the ability to modify the PDA surface for
variety of water treatment systems, collectively make PDA/BNC membrane demonstrated here a
promising and powerful candidate for wastewater treatment.
We have designed and demonstrated a highly efficient organic dye removal catalytic membrane
based on BNC loaded with mPDA and Pd nanoparticles for wastewater treatment. Key factors
which enable the Pd-mPDA-BNC membrane to be effective in dye removal are: synergistic
effect of dye adsorption on mPDA and catalytic ability of Pd nanoparticles in presence of
NaBH4; highly porous structure due to the addition of mPDA nanoparticles, which increases the
specific surface area for higher adsorption and degradation; and uniform and high loading of Pd
nanoparticles within the entire membrane. The membrane fabrication process is simple and is
easily scalable. The Pd-mPDA-BNC membrane exhibited excellent dye removal performance as
well as the ability for the treatment of multiple contaminants with different chemical structures
and charges simultaneously. The membrane exhibited significantly higher water flux compared
to commercially available membranes even under low vacuum pressure. The facile and the
scalable fabrication of the membrane along with excellent dye removal efficiency and higher
water flux makes it a highly attractive candidate for wastewater treatment even at industrial
scales.
We have also shown the design and synthesis technique of a core-shell nanostructure based on
highly biocompatible and completely biodegradable components, where the photothermal
property of the core was integrated with NIR-responsive drug release properties of the shell for
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ultimately generating a robust and long-lasting anti-tumor immune response. PDA nanoparticles
were employed as a photothermal core and mesoporous silica shell was used as the carrier for a
mixture of phase-change material (1-tetradecanol) and immune-stimulating agent (gardiquimod).
These nanoparticles were effectively uptaken by cancer cells and led to concurrent release of
both antigens from the cancer cells (through immunogenic cell death) and adjuvant from the
nanoparticles upon NIR irradiation. The external trigger NIR facilitated spatiotemporal control of
the therapeutic events for ultimately mounting a potent anti-tumor immune response. The coreshell nanoparticle design is universal and is amenable for loading other types of
immunomodulatory or chemotherapeutic drugs or their combinations for synergistic effects. The
versatility and unique design of these multifunctional nanoparticles can be harnessed for
improved photothermal-immunotherapeutic treatments acting as a powerful platform for cancer
treatment.
Furthermore, we have demonstrated the reversible and graded control of the electrical activity of
excitable cells using PDA nanoparticles as biocompatible and biodegradable photothermal
transducers. In the presence of PDA nanoparticles, the spike rate of neurons is significantly
suppressed under NIR laser irradiation with a power density as low as 3 mW mm -2. With a
progressive increase in the laser power density, we observed a monotonic decrease in the spike
rate. The activity recovery time was found to be dependent on irradiation power density and
irradiation duration. In the presence of PDA nanoparticles, the beating rate of cardiomyocyte
tissues progressively increased as the irradiation laser power density increased from 4 to 14 mW
mm-2. To improve the ease of interfacing the photothermal agents with neural cultures and brain
tissues, we have designed and realized a 3D collagen/polydopamine nanoparticle foam and
applied it on the cultured neurons as an “add-on” patch. The 3D foam demonstrated superior
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photothermal and neuromodulation performance compared to colloidal polydopamine
nanoparticles. Compared to inorganic photothermal nanostructures (e.g., noble metal
nanoparticles), PDA nanostructures are better suited for in vivo neuromodulation owing to their
high biocompatibility and biodegradability. We believe that this novel nanomaterial platform for
non-invasive neuromodulation can be easily extended to other excitable cells both ex vivo and in
vivo and serve as a valuable tool in neuro-engineering.

6.2 Significance and Outlook
In addition to the representative nanomaterials and applications demonstrated in this dissertation,
the fabrication strategies and design principles demonstrated in this work can have far reaching
implications to realize various nanocomposites with applications in water purification, energy
harvesting,

cancer

treatment

and

neuroscience.

By

harnessing

polydopamine-based

biocompatible and biodegradable organic materials, a wide variety of functional materials and
nanocomposites can be achieved in a facile and controllable way.
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Appendix
Appendix 1
Gold nanoparticle (AuNP) synthesis:

AuNPs were synthesized using a seed-mediated

method.221 Au seeds with a diameter of 3 nm were synthesized by addition of ice-cold sodium
borohydride (0.6 ml, 10 mM) into a mixture of hexadecyltrimethylammonium bromide CTAB
(9.75 ml, 0.1 M) and gold chloride trihydrate (0.25 ml, 10 mM) under vigorous stirring. AuNPs
with a dimeter of 5 nm were synthesized by mixing CTAC (2 ml, 0.2 M), ascorbic acid (1.5 ml,
0.1 M) and 3 nm as-prepared seed (1 ml) and addition of gold chloride solution (2 ml, 0.5 mM)
under vigorous stirring for 15 minutes. For 10 nm AuNPs, CTAC (7 ml, 0.2 M), ascorbic acid
(5.25 ml, 0.1 M) and 3 nm as-prepared seed (0.175 ml) were mixed and added with gold chloride
solution (7 ml, 0.5 mM) under vigorous stirring for 15 minutes.

131

Table S2. 1 Parameters of Langmuir Isotherm models for adsorption of Pb (II) and R6G onto
PDA/BNC foams.
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Figure S2. 1 Raman spectra of the dopamine monomer and polydopamine particles.
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Figure S2. 2 (A) Photograph and SEM images of (B) surface and (C) cross-section of the freezedried pristine BNC (BNC foam).
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Figure S2. 3 Optical image (A) and SEM of the surface (B) of the BNC membrane (air-dried
BNC).
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Figure S2. 4 Weight loss profiles of BNC, PDA particles and PDA/BNC composite as measured
by thermogravimetric analysis (TGA).
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Figure S2. 5 (A) XPS spectra of PDA/BNC before and after the Pb (II) adsorption test. Pb 4f
spectra of Pb (II) in (B) Pb(NO3)2 powder and (C) after adsorption on PDA/BNC.
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Figure S2. 6 Comparison between PDA nanoparticle and activated carbon in Pb (II) adsorption
(the weight of the both adsorbents was 80 mg, NOTE: error bars are small compared to scale of
the graph).
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Figure S2. 7 Adsorption capacities of PDA/BNC foam for Cd (II) (A), and MB (B) at different
pH values (Experiments carried out at room temperature and the initial concentration of the
contaminants was 200 ppm).
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Figure S2. 8 (A) Pore size investigation for BNC membrane. 5 nm AuNP solution diffusion test
(left and center) that shows no particle diffuses through the membrane and a upper limit for the
pore size. The diffusion test repeated for DL-Tryptophan, R6G, and Lysozyme (right), and all
these molecules are diffusing through the BNC membrane giving a lower limit of roughly 1 nm
pore size for the membrane. (B) Pore size study for PDA/BNC membrane using 5 nm (left) and
10 nm (right) AuNPs using vacuum filtration at 0.7 bar pressure. The 5 nm AuNPs penetrate
through the membrane suggesting that pore size of the membrane is larger than 5 nm, while 10
nm AuNPs dont penetrate through the membrane even after 4 hours of solution filtration. This
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gives a lower limit of 5 nm and upper limit of 10 nm for the pore size of the PDA/BNC
membrane. (C) Contact angle measurements for pristine BNC and PDA/BNC membranes.
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Figure S2. 9 (A) Chemical structures of model positively charged dyes used in cocktail filtration
test. (B) UV-Vis spectra of the cocktail solution before and after the filtration.

142

A

B

Absorbance (a.u.)

Concentration (ppm)

1.0
60
50
40

Methyl Orange

30
20

0.5

Before

After

10

0.0
0
Original
0

5

10

15

20

25

30

300

35

400

500

600

Wavelength (nm)

Filtered Water Volume (ml)

Figure S2. 10 (A) Concentrations of negatively charged MO in feed and permeate water
solutions during filtration test (initial pH value was ~2.4). (B) UV-Vis spectra of the MO before
and after the filtration test (inset shows the chemical structure of MO).
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Appendix 2
Gold nanoparticle (AuNP) synthesis:

AuNPs were synthesized using a seed-mediated

method.221 Au seeds with a diameter of 3 nm were synthesized by addition of ice-cold sodium
borohydride (0.6 ml, 10 mM) into a mixture of hexadecyltrimethylammonium bromide CTAB
(9.75 ml, 0.1 M) and gold chloride trihydrate (0.25 ml, 10 mM) under vigorous stirring. AuNPs
with a dimeter of 5 nm were synthesized by mixing CTAC (2 ml, 0.2 M), ascorbic acid (1.5 ml,
0.1 M) and 3 nm as-prepared seed (1 ml) and addition of gold chloride solution (2 ml, 0.5 mM)
under vigorous stirring for 15 minutes. For 10 nm AuNPs, CTAC (7 ml, 0.2 M), ascorbic acid
(5.25 ml, 0.1 M) and 3 nm as-prepared seed (0.175 ml) were mixed and added with gold chloride
solution (7 ml, 0.5 mM) under vigorous stirring for 15 minutes.

Thermogravimetric Analysis (TGA): Thermogravimetric analysis (TGA) was employed to
analyze the mass loading of Pd in Pd-BNC and Pd-mPDA-BNC membranes (Figure S3.3). For
Pd-mPDA-BNC, the first mass loss of ~6% can be attributed to residual/absorbed water at 100
o

C, second mass loss of ~6% at 280 oC can be attributed to the degradation of cellulose and

mPDA particles and a mass loss of ~30% at 350 oC can be attributed to the decomposition of
cellulose residue, which generates CO2 and H2O, and further degradation of mPDA particles.222
After heating to 600 oC, the remaining mass (~46%) is composed of Pd nanoparticles and carbon
residues. The mass of carbon residues for mPDA-BNC at 600 oC is ~25.7%. Based on the above
discussion, the mass loading of Pd in Pd-mPDA-BNC membrane was calculated to be ~20.3
wt%. However, in the case of Pd-BNC, the mass loading of Pd was calculated to be ~13.6 wt%.
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Environmental Impact of Sodium Borate: Environmental Protection Agency’s (EPA)
guidelines states that Lowest Observed Adverse Effect Level (LOAEL) for oral exposure (e.g.
drinking) of boric acid and sodium borate is between 32 mg/kg/day and 46 mg/kg/day.223
LOAEL shows the lowest dose at which there was an observed toxic or adverse effect. By
assuming that a toddler has an average weight of 15 kg and drinks 2 liters of water every day, the
LOAEL limit would be between 480 mg and 690 mg. In our experiments, maximum final
concentration of NaBH4 is 2.5 mM and by assuming that 100% of it has reacted and turned into
sodium borate, 2 liters of filtered water contain 329 mg of sodium borate, which is below the
lower limit of LOAEL.
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Figure S3. 1 Cross section SEM images of the (A) BNC membrane and (B) Pd-mPDA-BNC
membrane. (Insets show corresponding higher magnification SEM images. )
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Figure S3. 2 (A) SEM and (B) AFM images of the surface of the Pd-BNC membrane.
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Figure S3. 3 Weight loss profiles of BNC, Pd-BNC, mPDA-BNC and Pd-mPDA-BNC
composites obtained by TGA.
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Figure S3. 4 XPS spectra of mPDA-BNC and Pd-mPDA-BNC membranes confirming the
presence of metallic Pd.

149

Figure S3. 5 mPDA vs PDA nanoparticle efficiency in removing (A) MO, (B) 4NP and (C) MB
at different pH values.
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Figure S3. 6 Effect of 1.5 mM NaBH4 on the absorbance of the MO after 20 minutes.
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Figure S3. 7 (A) Absorbance of MO solution before and after filtration through BNC membrane
in presence of NaBH4. (B) Absorbance of MO solution before and after filtration through PdmPDA-BNC membrane in the absence of NaBH4.
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Figure S3. 8 Particle rejection test. (A) TEM image of the 5 nm AuNPs used for praticles
rejection test on Pd-mPDA-BNC membrane. (B) Extinction spectra of the AuNP feed solution
and the permeate after filtration through Pd-mPDA-BNC membrane (Inset shows corresponding
optical image of the solution).
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Appendix 3
Analysis of TGA data: 31% of the weight of PDA was retained after heating to 600 °C under
nitrogen. Mesoporous silica-coated PDA showed an initial mass loss of about 20% at 100 °C,
due to water evaporation. It lost its weight less dramatically mainly because of the presence of
the silica coating and retained 56% of the total weight after heating to 600 °C. This indicates that
silica coating accounts for about 53% of the weight of core-shell PDA@mSiO2 nanoparticles
(Figure 4.1H).
Loading and release of LT680: Successful loading and controlled release of payload from the
PDA@mSiO2 nanoparticles was further investigated using a fluorescent dye, LT680. Following
the loading procedure, the PDA@mSiO2 nanoparticles exhibited significantly higher
fluorescence intensity compared to the supernatant (corresponding to the unloaded dye in
solution), confirming the successful loading of dye in solution (Figure S4.5A). Under laser
irradiation (power of 14 mW/mm2) the fluorescence intensity of solution monotonically
increased with time. This experiment demonstrates the successful loading and release of the
LT680 dye, that can be used for studying nanoparticle uptake and subsequent release of drug
from within the cells in vitro.

Photothermal efficiency calculation: The photothermal conversion efficiency for mSiO2-PDA
was measured using a method reported previously.224 To obtain the temperature data, 300 µl of
mSiO2-PDA solution (1 mg/ml) was irradiated with 808 nm laser (power 0.4 W, power density
14 mW/mm2) for six minutes so that the solution temperature reaches steady-state. Laser was
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turned off at six minutes and solution temperature was monitored for another six minutes to
follow the cooling kinetics. Same test was carried out with deionized water.
The energy input by nanoparticles is given by:224
(S4.1)
Where is laser power (W),

is the nanoparticle absorbance at 808 nm and

is the

photothermal conversion efficiency.
The heat dissipated to the environment is given by:
(S4.2)
Where

is the heat transfer coefficient (W/cm.K),

is the surface area (cm2) and

is the

ambient temperature (K).
When the steady-state condition is reached, the energy input is equal to energy output:
(S4.3)
Where

is the heat generated by water from laser irradiation. By combining equation 1 and 2,

the photothermal conversion efficiency can be deduced to be:

(S4.4)

In order to calculate the

, a non-dimensional temperature

is defined as:

(S4.5)
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A typical time constant could be written as follows:

(S4.6)

Where

is the weight and

is the specific heat capacity. Using conservation of energy during

the cooling stage and equations (5) and (6):

(S4.7)

By integrating the above equation:
(S4.8)
This means, the system‘s time constant is the slope of the linear fit between time and
during the cooling stage.

From the slope of the above graph, we obtain
equation (6), giving

sec. The

(W/K). Then,
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is calculated using

is calculated using equation below:

(S4.9)
Considering that the temperature rise for deionized water is 0.5 K, Qw is calculated to be 0.0029
W.
Then, the photothermal conversion efficiency of the nanoparticles is calculated by using equation
(4). Laser power is 0.4 W,
photothermal conversion efficiency

and with
.
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, we calculate the

Figure S4. 1 SEM image of as-prepared silica-coated PDA nanoparticles before removing the
pore-template (CTAB).
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Figure S4. 2 HRTEM image of PDA@mSiO2 nanoparticles and corresponding EDS elemental
mapping for N and Si, showing the presence of PDA core and silica shell.
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Figure S4. 3 (A) Absorbance spectra of PDA and PDA@mSiO2 nanoparticles. (B) TEM images
of the PDA@mSiO2 nanoparticles before and after 10 minutes laser treatment.
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Figure S4. 4 In vitro maturation of BMDCs indicated by upregulation of maturation markers:
CD40, and CD80.

161

Figure S4. 5 (A) (Left) FL images of the water (control), supernatant of loaded particles and
LT680 loaded PDA@mSiO2 particles showing efficient dye loading without free dye in solution.
(right) NIR-triggered release of LT680 dye from PDA@mSiO2 versus laser irradiation time (808
nm, 14 mW/mm2). (B) Nanoparticle uptake by cancer cells. Confocal fluorescence images of
B16-F10 cells incubated with LT680-mPDA nanoparticles. Scale bar: 50 µm.
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Figure S4. 6 (A) IR images of the mouse melanoma model when tumor was ablated with laser
(808 nm, 14 mW/mm2) with and without PDA@mSiO2 nanoparticle injection. (B) Changes in
local tumor temperature when ablated with different laser power densities with and without
PDA@mSiO2 nanoparticle injection. (C) Fluorescence images of mouse tumor acquired before
injection (blank) and after LT680-loaded mPDA injection (LT680-mPDA and LT680-mPDA 10
minute without NIR) and after 5 minutes of NIR treatment (LT680-mPDA with 5 min NIR). (D)
Fold increase in fluorescence intensity (FI) with and without NIR treatment (n=3). Data
represented as mean ± SD. * p<0.05 by Unpaired t test with Welch's correction.
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Figure S4. 7 Relative populations and activation status of immune cells in tumor draining lymph
node at day 16. Representative flow cytometry plots of (A) CD11c+ CD40+ dendritic cells, (B)
CD11c+ MHCII+ dendritic cells. Percentage positive cells are displayed on top right corner.
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Figure S4. 8 Percentage of different immune cells present in tumor draining lymph node (n=3).
Data represented as mean ± SD.
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Figure S4. 9 Therapeutic effect of increasing NIR treatment duration to 10 minutes. (A) Timeline
of experiment. (B) In vivo toxicity of gardi-mPDA and 10 minute NIR assessed by change in
body weight of the mice, (C) tumor growth curves, (D) survival curve of mice given different
treatments (n=5). (E) Tumor volume after secondary challenge in mice surviving after gardimPDA-NIR treatment and PDA@mSiO2-NIR (n=2). Data represented as mean ± SD. * p<0.05,
** p<0.01 and **** p<0.0001 by one-way ANOVA with Tukey’s posttest and Log-rank
(Mantel-Cox) test for survival curve.
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Appendix 4

Figure S5. 1 Zeta potential measurements of Polydopamine nanoparticles in PBS, pH=7.4.
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Figure S5. 2 A single trace of spike recording at half an hour interval. Neurons were not treated
with PDA NP and are not subject to any external stimulation
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Figure S5. 3 Control experiments: Effect of laser irradiation on neuron activity without PDA NP
treatment. A single trace of spike recording (left) and mean spike rate (right). Unpaired Twosamples t-test; panel (A): p= 0.7928, n=32, panel (B): p= 0.661927, n=38.
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Figure S5. 4 (A) Correlation coefficient matrix for repeated laser photothermal stimulation in
presence of PDA NP. Highly correlated spike activity across the culture during the laser
application indicates the culture wide and universal effect of the treatment. (B) Box plot displays
the spike reduction percentage during the photothermal stimulation for each cycle and the its
distribution across diffeent electrodes. Close to 1oo percent average activity reduction and low
scattering across electrodes demonstrates the culture-wide effectiveness of the photothermal
stimulation.
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Figure S5. 5 Overlaid waveform of hippocampal neurons treated with PDA NP, before and after
NIR laser irradiation. Data were collected for laser power density of 6 mW.mm-2 where neuron
activities were completely suppressed during NIR irradiation. Panel (A) shows the spike cutouts
before the application of laser and panel (B) shows the spike cutouts after the laser irradiation
was finished.
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Figure S5. 6 The full trace of field potential recording of iPS-derived cardiomyocytes on MEA
system. The iPS-CMs were seeded on MEA recording probe for 3 days until stable field potential
was observed. The iPS-CMs was treated with PDA nanoparticle for 24 hours and washed off
before recording. The full recording was 300-seconds long. The 808 laser was turned on for
duration of 10, 20 and 30 seconds with power density of 14 mW.mm-2.
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Figure S5. 7 Extreme heat effect on iPS-derived cardiomyocytes. (A) The full trace of field
potential recording of iPS-CM treated with PDA nanoparticle for 24 hours and heated by 808
laser at power density of 25 mW.mm-2. (B) The normalized beating rate of iPS-CMs showed the
beating rate increased at the beginning of laser heating, but ceased beating shortly after
increasing, experiencing complete stop of beating during the laser treatment. The activity
recovered after the laser was turned off, and the frequency of the beating changed afterward.

Figure S5. 8 Optical images of (A) pristine collagen foam and (B) collagen foam modified with
PDA NP (dark color comes from PDA NP immobilization on collagen surface).
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Figure S5. 9 Temperature changes of collagen foam + PDA NP in dry state at different laser
power densities (808 nm laser duration for 10, 20 and 30 seconds).
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